# EDGAR Filing Document

**Accession Number:** 0001803958
**File Stem:** 0001193125-25-314149
**Filing Date:** 2025-12
**Character Count:** 134323
**Document Hash:** bbc3c59675799b051ab3ec635f25c768
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-25-314149.hdr.sgml**: 20251210

**ACCESSION NUMBER**: 0001193125-25-314149

**CONFORMED SUBMISSION TYPE**: SC TO-I

**PUBLIC DOCUMENT COUNT**: 18

**FILED AS OF DATE**: 20251210

**DATE AS OF CHANGE**: 20251210

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** KKR Real Estate Select Trust Inc.
- **CENTRAL INDEX KEY:** 0001803958

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** MA
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC TO-I
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-92816
- **FILM NUMBER:** 251561950

**BUSINESS ADDRESS:**
- **STREET 1:** 30 HUDSON YARDS
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10001
- **BUSINESS PHONE:** 2127508300

**MAIL ADDRESS:**
- **STREET 1:** 30 HUDSON YARDS
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10001

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** KKR KREST Fund Inc.
- **DATE OF NAME CHANGE:** 20200219
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** KKR Real Estate Select Trust Inc.
- **CENTRAL INDEX KEY:** 0001803958

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** MA
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC TO-I

**BUSINESS ADDRESS:**
- **STREET 1:** 30 HUDSON YARDS
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10001
- **BUSINESS PHONE:** 2127508300

**MAIL ADDRESS:**
- **STREET 1:** 30 HUDSON YARDS
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10001

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** KKR KREST Fund Inc.
- **DATE OF NAME CHANGE:** 20200219

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549** 

**SCHEDULE TO** 

**(Rule 13e-4)** 

**TENDER OFFER STATEMENT PURSUANT TO SECTION 14(D)(1) OR 13(E)(1)** 

**OF THE SECURITIES EXCHANGE ACT OF 1934** 

## KKR Real Estate Select Trust Inc.
**(Name of Issuer)** 

**(Name of Person(s) Filing Statement)** 

**Class I, Class D, Class S and Class U Shares of Common Stock** 

**(Title of Class of Securities)** 

**49836N502, 49836N304, 49836N106 and 49836N403** 

**(CUSIP Number of class of securities)** 

**Lori Hoffman** 

**c/o KKR Registered Advisor LLC** 

**30 Hudson Yards** 

**New York, New York 10001** 

**(212) 750-8300** 

**(Name, Address and Telephone No. of Person Authorized to** 

**Receive Notices and Communications on Behalf of the Person(s) Filing Statement)** 

***With a copy to:***

**Rajib Chanda, Esq.** 

**Nathan D. Smogie, Esq.** 

**Benjamin C. Wells, Esq.** 

**Simpson Thacher & Bartlett LLP** 

**900 G Street, N.W.** 

**Washington, DC 20001** 

**December 10, 2025** 

**(Date Tender Offer First Published, Sent or Given to Security Holders)** 

**CALCULATION OF REGISTRATION FEE** 

☐ Check the box if the filing relates solely to preliminary communications made before commencement of a tender offer.

Check the appropriate boxes below to designate any transactions to which the statement relates:

☐ third-party tender offer subject to Rule 14d-1.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;☒ issuer tender offer subject to Rule 13e-4.

☐ going-private transaction subject to Rule 13e-3.

☐ amendment to Schedule 13D under Rule 13d-2

Check the following box if the filing is a final amendment reporting the results of the tender offer: ☐

------

**Item 1.** **Summary Term Sheet.** <br>

Reference is made to the Summary Term Sheet of the Offer to Purchase (as defined below) that is attached hereto as Exhibit (a)(1)(ii) and is hereby incorporated by reference.

**Item 2.** **Subject Company Information.** <br>

(a) The name of the issuer is KKR Real Estate Select Trust Inc. (the "Fund"). The Fund is a non-diversified, closed-end management investment company registered under the Investment Company Act of 1940, as amended (the "1940 Act"). It is organized as a
Maryland corporation. The principal executive office of the Fund is located at 30 Hudson Yards, New York, New York 10001 and the telephone number is (212) 750-8300.

(b) The title of the securities that are the subject of the offer to purchase and the related Letter of Transmittal
("Offer to Purchase" and the tender offer made thereby, the "Offer") are Class I shares of common stock (the "Class I Shares"), Class D shares of common stock (the "Class D
Shares"), Class S shares of common stock (the "Class S Shares") and Class U shares of common stock (the "Class U Shares" and, together with the Class I Shares, Class D Shares and
Class S Shares, the "Shares") or portions thereof. As of the close of business on November 26, 2025, there were approximately 58,757,571 Shares outstanding. Subject to the conditions set forth in the Offer to Purchase, the Fund
will purchase up to 2,937,879 Shares that are tendered by holders of the Fund's Shares ("Stockholders") and not withdrawn as described in the Offer to Purchase (the "Offer Amount"). The Shares subject to the Offer
represent approximately 5% of the Fund's Shares outstanding as of November 26, 2025.

(c) Shares are not traded in any market.

**Item 3.** **Identity and Background of Filing Person.** <br>

(a) The Fund is tendering for its own Shares. The information required by this Item is set forth in Item 2(a)
above. KKR Registered Advisor LLC (the "Adviser") serves as the investment manager for the Fund. The Adviser is located at 30 Hudson Yards, New York, New York 10001 and its telephone number is (212) 750-8300. The members of the Fund's Board of Directors (the "Board") are Ralph Rosenberg, Julia Butler, Matt Salem, Fran Bermanzohn, Joan Binstock, James Kropp and Susan Meaney
(each, a "Director"). The Chief Executive Officer and President is Julia Butler, the Chief Operating Officer is Nicholas O'Neill, the Chief Financial Officer, Chief Accounting Officer and Treasurer of the Fund is Megan Gaul, the
Chief Legal Officer and Secretary is Lori Hoffman, the Chief Compliance Officer is James Amler and Head of Investor Relations is Doug Krupa. The Directors and the executive officers of the Fund may be reached at the Fund's business address and
phone number set forth in Item 2(a) above.

(b)-(c) Not applicable.

**Item 4.** **Terms of the Transaction.** <br>

(a)(1)(i) Subject to the conditions set forth in the Offer to Purchase, the Fund will purchase up to 2,937,879 Shares that are tendered by Stockholders by 4:00 p.m., Eastern Time, on January 9, 2026 and not withdrawn as described in Item 4(a)(1)(vi).

(ii) The purchase price of a Share (or portion thereof) tendered will be its net asset value as of January 9,
2026 or a later date determined by the Fund if the Offer is extended (in each case, the "Valuation Date"), upon the terms and subject to the conditions set forth in the Offer to Purchase. Reference is made to the Cover Page,
Section 2 "Offer to Purchase and Price" and Section 6 "Purchases and Payment" of the Offer to Purchase, which are incorporated herein by reference.

(iii) The Offer is scheduled to expire on January 9, 2026 unless extended. Reference is made to the Cover Page,
Summary Term Sheet, Section 2 "Offer to Purchase and Price" and Section 5 "Withdrawal Rights" of the Offer to Purchase, which are incorporated herein by reference.

(iv) Not applicable.

------

(v) Reference is made to the Cover Page, Summary Term Sheet and Section 7 "Certain Conditions of the
Offer" of the Offer to Purchase, which are incorporated herein by reference.

(vi) Reference is made to Section 5 "Withdrawal Rights" of the Offer to Purchase, which is
incorporated herein by reference.

(vii) Reference is made to the Cover Page, Section 4 "Procedure for Tenders" and Section 5
"Withdrawal Rights" of the Offer to Purchase, which are incorporated herein by reference. **Note that certain Stockholders may be required to deliver their Letter of Transmittal to their Financial Advisor (instead of directly to SS&C Global Investor & Distribution Solutions, Inc.). All Stockholders tendering Shares should carefully review their Letter of Transmittal and follow the delivery instructions therein.** 

(viii) Reference is made to Section 4 "Procedure for Tenders" and Section 6 "Purchases and
Payment" of the Offer to Purchase, which are incorporated herein by reference.

(ix) Reference is made to the Cover Page, Section 3 "Amount of Tender," and Section 6
"Purchases and Payment" of the Offer to Purchase, which are incorporated herein by reference.

(x) Reference is made to Section 2 "Offer to Purchase and Price," which is incorporated herein by
reference.

(xi) Not applicable.

(xii) Reference is made to Section 10 "Certain Federal Income Tax Consequences" of the Offer to
Purchase, which is incorporated herein by reference.

(a)(2) Not applicable.

(b) Any Shares to be purchased from any officer, Director or affiliate of the Fund will be on the same terms and
conditions as any other purchase of Shares. To the Fund's knowledge, none of the officers, Directors, or affiliates of the Fund intends to tender Shares in the Offer.

**Item 5.** **Past Contracts, Transactions, Negotiations and Agreements With Respect to the Issuer's Securities.** <br>

(a)-(d) Not applicable.

(e) The Fund's Prospectus dated April 23, 2025, as amended and/or supplemented from time to time (the
"Prospectus"), provides that the Board has the discretion to determine whether the Fund will purchase Shares from Stockholders from time to time pursuant to written tenders. The Adviser expects that it will recommend to the Board that
the Fund purchase Shares from Stockholders quarterly. However, the Fund is not required to conduct tender offers. The Fund does not know of any other contract, agreement, arrangement, or understanding, whether contingent or otherwise or whether or
not legally enforceable, between the (i) Fund, any of the Fund's executive officers or Directors, any person controlling the Fund, or any executive officer or director of any corporation ultimately in control of the Fund and (ii) any
other person with respect to any securities of the Fund (including any contract, agreement, arrangement, or understanding concerning the transfer or the voting of any such securities, joint ventures, loan or option arrangements, puts or calls,
guarantees of loans, guarantees against loss, or the giving or withholding of proxies, consents or authorizations).

**Item 6.** **Purposes Of This Tender Offer And Plans Or Proposals.** <br>

(a)-(b) Reference is made to Section 1 "Background and Purpose of the Offer" of the Offer to Purchase, which is incorporated herein by reference.

(c) Reference is made to Section 8 "Certain Information About the Fund" of the Offer to Purchase,
which is incorporated herein by reference. Because Shares are not traded in any market, subsections (6), (7), and (8) of Regulation M-A Item 1006(c) are not applicable to the Fund.

------

**Item 7.** **Source and Amount of Funds or Other Consideration.** <br>

(a)-(b) Reference is made to Section 6 "Purchases and Payment" of the Offer to Purchase, which is incorporated herein by reference.

(c) Not applicable.

(d) None of the Fund, the Adviser or the Board or any person controlling the Fund, the Adviser or the Board has
determined at this time to borrow funds to purchase Shares tendered in connection with the Offer. Depending on the dollar amount of Shares tendered and prevailing general economic and market conditions, the Fund, in its sole discretion, may decide
to seek to borrow money to fund all or a portion of the purchase amount for Shares, subject to compliance with applicable law. The Fund expects that the repayment of any amounts borrowed will be financed from additional funds contributed to the Fund
by existing or new Stockholders.

**Item 8.** **Interest in Securities of the Issuer.** <br>

(a) Based on the number of Shares outstanding as of November 26, 2025, the following persons own the number of
Shares indicated in the below table.

---

| | | |
|:---|:---|:---|
| **Person** | **Shares** | **Percentage of the Fund's<br>Outstanding Shares** |
|  Adviser | 10954992.20 | 18.64% |
|  Ralph Rosenberg | 47439.66 | \* |
|  Fran Bermanzohn | 12723.91 | \* |
|  Joan Binstock | 15579.69 | \* |
|  James Kropp | 21907.73 | \* |
|  Susan Meaney | 11264.24 | \* |
|  Nicholas O'Neill |  | \* |
|  Megan Gaul |  | \* |
|  Julia Butler | 3935.50 | \* |
|  James Amler |  | \* |
|  Lori Hoffman |  | \* |
|  Doug Krupa |  | \* |
|  Matt Salem |  | \* |

---

\* Less than 1%. 

None of the persons listed above intends to tender any of his or her Shares in the Offer. Addresses for each of the persons listed above are provided in Item 3.

(b) Reference is made to Section 8 "Certain Information About the Fund" of the Offer to Purchase,
which is incorporated herein by reference. Other than the issuance of Shares by the Fund in the ordinary course of business, there have been no transactions in Shares effected during the past sixty (60) days by the Fund, the Adviser, or any
Director or officer of the Fund, or any person controlling the Fund or the Adviser.

**Item 9.** **Persons/Assets Retained, Employed, Compensated or Used.** <br>

(a) No persons have been employed, retained, or are to be compensated by the Fund to make solicitations or
recommendations in connection with the Offer to Purchase.

**Item 10.** **Financial Statements.** <br>

(a) Not applicable. The consideration offered to security holders consists solely of cash. The Offer is not subject
to any financing condition, and the Fund is a public reporting company under Section 13(a) of the Exchange Act that files reports electronically on EDGAR. The information under the caption "Section 11—Financial
Statements" in the Offer to Purchase is incorporated herein by reference.

------

(b) Not applicable.

**Item 11.** **Additional Information.** <br>

(a) (1) None.

(2) None. <br>

(3) Not applicable.

(4) None. <br>

(5) None. <br>

(c) The Offer to Purchase, attached hereto as Exhibit (a)(1)(ii), is incorporated herein by reference in its
entirety.

**Item 12.** **Exhibits.** <br>

(a)(1) [(i) Cover Letter to Offer to Purchase and Letter of Transmittal.](d949685dex99a1i.htm)

[(ii) Offer to Purchase.](d949685dex99a1ii.htm)

[(iii) Forms of Letter of Transmittal.](d949685dex99a1iii.htm)

[(iv) Forms of Notice of Withdrawal of Tender.](d949685dex99a1iv.htm)

(a)(2)-(4) Not applicable.

(b) Not applicable.

(d) Not applicable.

(g) Not applicable.

(h) Not applicable.

[Filing Fee Exhibit.](d949685dexfilingfees.htm)

------

**SIGNATURE** 

After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

---

| | |
|:---|:---|
|  KKR REAL ESTATE SELECT TRUST INC. | KKR REAL ESTATE SELECT TRUST INC. |
| By: | /s/ Lori Hoffman |
| Name: | Lori Hoffman |
| Title: | Chief Legal Officer and Secretary |

---

Dated: December 10, 2025

------

**EXHIBIT INDEX** 

---

| | |
|:---|:---|
| **Exhibit** |  |
| (a)(1)(i) | [Cover Letter to Offer to Purchase and Letter of Transmittal.](d949685dex99a1i.htm) |
| (a)(1)(ii) | [Offer to Purchase.](d949685dex99a1ii.htm) |
| (a)(1)(iii) | [Forms of Letter of Transmittal.](d949685dex99a1iii.htm) |
| (a)(1)(iv) | [Forms of Notice of Withdrawal of Tender.](d949685dex99a1iv.htm) |
| (b) | [Filing Fee Exhibit.](d949685dexfilingfees.htm) |

---

## Ex-99.(A)(1)(I)

**Exhibit (a)(1)(i)** 

---

| | |
|:---|:---|
| <br> ![LOGO](g949685g11g11.jpg) <br>| ![LOGO](g949685g08g08.jpg) |

---

## KKR Real Estate Select Trust Inc.
c/o KKR Registered Advisor LLC

30 Hudson Yards, New York, New York 10001

*If you do not want to sell your shares of common stock at this time, please disregard this notice. This is simply a notification of the Fund's repurchase offer.* 

December 10, 2025

Dear Stockholder:

This letter serves to inform you of important dates relating to a repurchase offer by KKR Real Estate Select Trust Inc. (the "Fund"). If you are not interested in tendering your shares of common stock in the Fund ("Shares") for repurchase at this time, please disregard this notice and take no action.

The tender offer period will begin on December 10, 2025 and ends at 4:00 p.m., Eastern Time, on January 9, 2026. The purpose of the tender offer is to provide liquidity to stockholders of the Fund. Shares may be presented to the Fund for repurchase only by tendering them during one of the Fund's announced tender offers.

If you do not wish to sell your Shares for any reason, simply disregard this notice. **No action is required if you do not wish to sell any portion of your Shares at this time.**

If you hold your Shares through a financial advisor, broker/dealer, or other financial intermediary, and you wish to tender all or some of your Shares during this tender offer period, please contact your intermediary as soon as possible for further instructions. Please be advised that your intermediary may require additional time to process repurchase requests on your behalf prior to the expiration of the tender offer period on January 9, 2026, and may have established an earlier deadline for submission of repurchase requests.

If you hold your Shares directly, rather than through an intermediary, and you wish to tender all or some of your Shares during this tender offer period, please complete the enclosed Letter of Transmittal and return it **by mail, fax , or email** to the Fund's Transfer Agent, SS&C Global Investor & Distribution Solutions, Inc., Attention: KKR Democratized Access Vehicles, c/o: SS&C GIDS, Inc., using one of the below options:

Regular Mail - P.O. Box 219302, Kansas City, MO 64121-9302

Overnight or Express Mail – 801 Pennsylvania Ave, Suite 219302, Kansas City, MO 64105-1307

Fax: (833) 674-0748

Email: <u>KKRREDEEM.ai@sscinc.com</u> 

**Note:** This is a submission box only, no response will be provided to any general or follow up inquiries.

**All Stockholders tendering Shares should carefully review their Letter of Transmittal and follow the delivery instructions therein.**

All tenders of Shares, whether submitted directly or processed through a financial intermediary, must be received in good order by the Fund's Transfer Agent by 4:00 p.m., Eastern Time, on January 9, 2026.

1 of 2

------

![LOGO](g949685g11g11.jpg)

If you have any questions, please refer to the attached Offer to Purchase document, which contains additional important information about the repurchase offer. Alternatively, you may contact your financial advisor or intermediary, if applicable. If you hold your Shares directly, you may call (855) 844-8655.

Sincerely,

KKR Real Estate Select Trust Inc.

2 of 2

------

---

| | |
|:---|:---|
| <br> ![LOGO](g949685g11g11.jpg) <br>| ![LOGO](g949685g08g08.jpg) |

---

c/o KKR Registered Advisor LLC.

30 Hudson Yards, New York, New York 10001

*FOR STOCKHOLDERS THROUGH MERRILL, LYNCH, PIERCE, FENNER & SMITH, INC. ("MERRILL")* 

*If you do not want to sell your shares of common stock at this time, please disregard this notice. This is simply a notification of the Fund's repurchase offer.* 

December 10, 2025

Dear Stockholder:

This letter serves to inform you of important dates relating to a repurchase offer by KKR Real Estate Select Trust Inc. (the "Fund"). If you are not interested in tendering your shares of common stock in the Fund ("Shares") for repurchase at this time, please disregard this notice and take no action.

The tender offer period will begin on December 10, 2025 and ends at 4:00 p.m., Eastern Time, on January 9, 2026. The purpose of the tender offer is to provide liquidity to stockholders of the Fund. Shares may be presented to the Fund for repurchase only by tendering them during one of the Fund's announced tender offers. **Because you hold your Shares through Merrill, if you wish to tender a portion or all of your Shares during this repurchase offer period, you must contact your investment professional and request to tender your Shares no later than 11:59 pm Eastern Time on January 8, 2026 (the "Merrill Repurchase Deadline") to allow for order processing. Merrill will tender your Shares to the Fund on your behalf. Do not submit repurchase requests directly to the Fund or its transfer agent as they will not be honored**.

If you do not wish to sell your Shares for any reason, simply disregard this notice. **No action is required if you do not wish to sell any portion of your Shares at this time.**

If you have any questions, please refer to the attached Offer to Purchase document, which contains additional important information about the repurchase offer, or call (855) 844-8655.

Sincerely,

KKR Real Estate Select Trust Inc.

1 of 1

## Ex-99.(A)(1)(Ii)

**Exhibit (a)(1)(ii)** 

---

| | |
|:---|:---|
|  ![LOGO](g949685g11g11.jpg)  | ![LOGO](g949685g08g08.jpg) |
|  ![LOGO](g949685g11g11.jpg)  |  |

---

## KKR Real Estate Select Trust Inc.
c/o KKR Registered Advisor LLC.

30 Hudson Yards, New York, New York 10001

*Offer to Purchase Up to 2,937,879 Shares of Common Stock Dated December 10, 2025* 

*The Offer and Withdrawal Rights Will Expire at 4:00 p.m., Eastern Time, on January 9, 2026, Unless the Offer is Extended* 

To the Stockholders of KKR Real Estate Select Trust Inc.:

Subject to the terms and conditions set forth in this offer to purchase ("Offer to Purchase") and the related Letter of Transmittal (which together with the Offer to Purchase constitutes the "Offer"), KKR Real Estate Select Trust Inc., a non-diversified, closed-end management investment company registered under the Investment Company Act of 1940, as amended (the "1940 Act") and organized as a Maryland corporation (the "Fund"), is offering to purchase up to 2,937,879 of its outstanding shares of common stock (including Class I shares of common stock, Class D shares of common stock, Class S shares of common stock and Class U shares of common stock, the "Shares") pursuant to tenders by stockholders of the Fund ("Stockholders") at a price equal to the net asset value ("NAV") per Share as of January 9, 2026 or a later date determined by the Fund if the Offer is extended (the "Valuation Date"). This Offer is currently scheduled to expire at 4:00 p.m., Eastern Time, on January 9, 2026 (the "Expiration Date"), but the Fund may extend this date; if it does, the Valuation Date may be changed. This Offer is being made to all Stockholders of the Fund and is not conditioned on any minimum amount of Shares being tendered, but is subject to certain conditions described below. Shares are not traded on any established trading market.

Stockholders should realize that the value of the Shares tendered in this Offer will likely change between the most recent time NAV was calculated and communicated to them and the Valuation Date (the relevant date for determining the value of the Shares tendered to the Fund for purposes of calculating the purchase price of such Shares) and such change could be material. The Fund generally determines the NAV of the Shares daily as of the close of regular trading on the New York Stock Exchange (normally, 4:00 p.m. Eastern Time). The most recently calculated NAV for each class of the Shares can be found by going to <u>www.krest.reit.</u> 

On June 4, 2024, KKR Alternative Assets LLC ("KAA"), an affiliate of KKR Registered Advisor LLC, the Fund's investment adviser (the "Adviser"), contractually committed to the Fund to continue to hold approximately 7,732,436 of Class I Shares currently owned by KAA, representing approximately $200 million based on the Fund's NAV as of May 28, 2024 (the "Support Shares"), through June 1, 2027 and, to the extent necessary, contribute such shares to the Fund to support a NAV per share of $27.00 on June 1, 2027. If on June 1, 2027 the Fund's NAV per share is less than $27.00 per share for any share class, KAA will contribute to the Fund as many of the Support Shares as are required, up to the maximum number of Support Shares, to reduce the number of outstanding shares and increase the NAV per share for each class of the Fund's shares up to $27.00 per share (the "Shareholder Priority Plan"). If the Fund's NAV per share for any class on June 1, 2027 is less than $27.00 per share and the contribution of all of the Support Shares is not sufficient to cause the NAV per share for each class to equal $27.00 per share, KAA will contribute all such Support Shares to support the Fund's NAV per share on such date. While the Shareholder Priority Plan is a contractual obligation to support

1 of 14

------

![LOGO](g949685g11g11.jpg)

the Fund's NAV per share, there is no guarantee that the contribution of the Support Shares will be sufficient to achieve a $27.00 per share NAV on June 1, 2027. For the avoidance of doubt, KAA is not obligated to contribute any of the Support Shares prior to June 1, 2027, and KAA is not obligated to contribute any of the Support Shares if the NAV per share for each class equals or exceeds $27.00 per share on June 1, 2027.

Stockholders desiring to tender all or any portion of their Shares in accordance with the terms of the Offer should complete and sign the attached Letter of Transmittal and mail or fax it to the Fund's transfer agent, SS&C Global Investor & Distribution Solutions, Inc. (the "Transfer Agent"), or the Stockholder's financial advisor, as applicable, in the manner provided for in the Letter of Transmittal and set forth in Section 4 "Procedure for Tenders" below.

**IMPORTANT** 

If you would like to participate in the Offer, and your Shares are held through a financial intermediary, such as a financial adviser, broker/dealer, or other nominee (each, a "Financial Intermediary"), please ask your Financial Intermediary to submit a repurchase request for you. You may be charged a transaction fee for this service by the intermediary.

**If you hold your Shares through a Financial Intermediary, you should be aware that the intermediary may establish its own earlier deadline for participation in the Offer.** Accordingly, if you hold your Shares through a Financial Intermediary and wish to participate in the Offer, you should contact the intermediary as soon as possible in order to determine the times by which you must take action in order to participate in the Offer. Each intermediary may establish its own specific deadline for receipt of completed repurchase request materials from its clients.

The Fund makes no recommendation to any Stockholder as to whether to tender or refrain from tendering Shares. Stockholders must make their own decisions whether to tender Shares and, if so, the portion of their Shares to tender.

Because each Stockholder's investment decision is a personal one, based on its financial circumstances, no person has been authorized to make any recommendation on behalf of the Fund as to whether Stockholders should tender Shares pursuant to the Offer. No person has been authorized to give any information or to make any representations in connection with the Offer other than those contained herein or in the Letter of Transmittal. If given or made, such recommendation and such information and representations must not be relied on as having been authorized by the Fund.

This transaction has not been approved or disapproved by the Securities and Exchange Commission or the Commodity Futures Trading Commission nor has the Securities and Exchange Commission, the Commodity Futures Trading Commission, or any state securities commission passed on the fairness or merits of such transaction or on the accuracy or adequacy of the information contained in this document. Any representation to the contrary is unlawful.

If you hold your Shares through a Financial Intermediary, please direct your questions and requests for assistance to your Financial Intermediary. If you hold your Shares directly, your questions and requests for assistance and requests for additional copies of the Offer may be directed to the Transfer Agent:

**SS&C Global Investor & Distribution Solutions, Inc.** 

**Regular Mail:** 

Attention: KKR Democratized Access Vehicles

c/o: SS&C GIDS, Inc.,

P.O Box 219302

Kansas City, MO 64121-9302

2 of 14

------

![LOGO](g949685g11g11.jpg)

**Overnight or Express Mail:** 

Attention: KKR Democratized Access Vehicles

c/o: SS&C GIDS, Inc.,

801 Pennsylvania Ave

Suite 219302

Kansas City, MO 64105-1307

Tel: (855) 844-8655 Fax: (833) 674-0748

Email: <u>KKRREDEEM.ai@sscinc.com</u>

Note: This is a submission box only, no response will be provided to any general or follow up inquires.

3 of 14

------

![LOGO](g949685g11g11.jpg)

 **Table Of Contents** 

---

| | | |
|:---|:---|:---|
|  **[Summary Term Sheet](#exa1ii949685_1)** | **[Summary Term Sheet](#exa1ii949685_1)** | **5** |
| **1.**  | **[Background and Purpose of the Offer](#exa1ii949685_2)**<br>| **6**  |
| **2.**  | **[Offer to Purchase and Price](#exa1ii949685_3)**<br>| **6**  |
| **3.**  | **[Amount of Tender](#exa1ii949685_4)**<br>| **7**  |
| **4.**  | **[Procedure for Tenders](#exa1ii949685_5)**<br>| **7**  |
| **5.**  | **[Withdrawal Rights](#exa1ii949685_6)**<br>| **8**  |
| **6.**  | **[Purchases and Payment](#exa1ii949685_7)**<br>| **8**  |
| **7.**  | **[Certain Conditions of the Offer](#exa1ii949685_8)**<br>| **9**  |
| **8.**  | **[Certain Information About the Fund](#exa1ii949685_9)**<br>| **9**  |
| **9.**  | **[Shareholder Priority Plan and NAV Support Agreement](#exa1ii949685_10)**<br>| **10**  |
| **10.**  | **[Full Tender by DRIP Participants](#exa1ii949685_11)**<br>| **11**  |
| **11.**  | **[Certain Federal Income Tax Consequences](#exa1ii949685_12)**<br>| **11**  |
| **12.**  | **[Miscellaneous](#exa1ii949685_13)**<br>| **14**  |
| **13.**  | **[Financial Statements](#exa1ii949685_14)**<br>| **14**  |

---

4 of 14

------

![LOGO](g949685g11g11.jpg)

**Summary Term Sheet**

**This is a summary of the features of the Offer. To understand the Offer fully and for a more complete discussion of the terms and conditions of the Offer, you should read carefully this entire Offer to Purchase and the related Letter of Transmittal.** 

• As disclosed in the Fund's prospectus dated April 23, 2025, as amended and/or supplemented from time to
time ("Prospectus"), the Fund may from time to time offer to repurchase a portion of its outstanding Shares pursuant to written tenders by Stockholders. Accordingly, the Fund is offering to purchase up to 2,937,879 Shares at a price
equal to their NAV (that is, the value of the Fund's total assets minus its total liabilities, divided by outstanding Shares) determined as of January 9, 2026 or such later date as may be determined by the Fund if the Offer is extended
(the "Valuation Date"). The Shares subject to the Offer represent approximately **5%** of the outstanding Shares as of November 26, 2025. The Offer, which begins on December 10, 2025, will remain open until 4:00 p.m.,
Eastern Time, on January 9, 2026 (the "Expiration Date"). The Fund reserves the right to adjust the Valuation Date to correspond to any extension of the Offer.

• Stockholders may tender all or a portion of their Shares.

• If an Investor tenders Shares and the Fund purchases those Shares, the Fund will effect payment for those Shares in
cash promptly after the Expiration Date.

• The Fund does not expect to impose any charges on repurchases of Shares in the Fund.

• If you tender only a portion of your Shares, you must maintain a minimum account balance of at least $1,000 as of
the Valuation Date. The Fund reserves the right to purchase all your Shares in the Fund if you tender less than all of your Shares and the number of Shares you tender would cause your account in the Fund to have a value lower than the required
minimum balance. The Offer is being made to all Stockholders and is not conditioned on any minimum amount of Shares being tendered.

• If the Fund accepts the tender of any of your Shares, your proceeds will be funded from one or more of the following
sources: cash on hand (including cash received from investments in the Fund), borrowings and/or proceeds from the sale of portfolio holdings.

• Additional repurchases will be made at such times and on such terms as may be determined by the Board of Directors
of the Fund (the "Board"). The Adviser expects that it will generally recommend to the Board that the Fund offer to repurchase a portion of its outstanding Shares four times each year, effective on or about January 15,
April 15, July 15 and October 15, but the Fund is not required to make any such offer.

• Following this summary is a formal notice of the Offer, which remains open until and through the Expiration Date,
unless extended. If you elect to tender your Shares, you have the right to change your mind and withdraw your tendered Shares at any time until the Expiration Date or, if such tendered Shares have not been accepted by the Fund, at any time after
February 9, 2026. If you would like to tender your Shares, you must complete the Letter of Transmittal enclosed with the Offer to Purchase, and return it as instructed in the Letter of Transmittal either (i) to the Transfer Agent,
Attention: KKR Democratized Access Vehicles, by (a) mail at P.O. Box 219302, Kansas City MO 64121-9302 (regular mail), or 801 Pennsylvania Ave, Suite 219302, Kansas City, MO 64105-1307 (overnight
mail), or (b) fax to (833) 674-0748, or (c) email to <u>KKRREDEEM.ai@sscinc.com</u>, or (ii) to your financial advisor, as directed. If you choose to fax the Letter
of Transmittal, please mail the original promptly after you fax it. Your properly completed mailed or faxed Letter of Transmittal must be received prior to the Expiration Date. If you decide to tender, it is your responsibility to, and the Fund
strongly recommends that you do, confirm receipt of your Letter of Transmittal (i) with your Financial Intermediary (if applicable), or (ii) with the Transfer Agent, by calling (855) 844-8655, Monday
through Friday, except holidays, during normal business hours of 9:00 a.m. to 6:00 p.m. (Eastern Time). All Stockholders tendering Shares should carefully review their Letter of Transmittal and follow the delivery instructions therein.

• The value of your Shares will likely change between the most recent time the NAV was calculated and communicated to
you and the Valuation Date (the date when the value of your investment will be determined for purposes of calculating the purchase price of your Shares). If you would like to obtain the estimated NAV of your Shares, visit the Fund's website at <u>www.krest.reit.</u> 

5 of 14

------

![LOGO](g949685g11g11.jpg)

**Summary Term Sheet** *(continued)*

• On June 4, 2024, KAA, an affiliate of the Adviser, contractually committed to the Fund to continue to hold
approximately 7,732,436 of the Support Shares, through June 1, 2027 and, to the extent necessary, contribute such shares to the Fund to support a NAV per share of $27.00 on June 1, 2027. If on June 1, 2027 the Fund's NAV per
share is less than $27.00 per share for any share class, KAA will contribute to the Fund as many of the Support Shares as are required, up to the maximum number of Support Shares, to reduce the number of outstanding shares and increase the NAV per
share for each class of the Fund's shares up to $27.00 per share. If the Fund's NAV per share for any class on June 1, 2027 is less than $27.00 per share and the contribution of all of the Support Shares is not sufficient to cause
the NAV per share for each class to equal $27.00 per share, KAA will contribute all such Support Shares to support the Fund's NAV per share on such date.

• If you are a participant in the Fund's distribution reinvestment plan ("DRIP"), in the event that
you elect to tender your Shares in full, your participation in the DRIP will be automatically terminated as of the applicable Expiration Date, and any distributions due but not yet paid as of such date will be paid in cash on the scheduled dividend
payment date.

• Please note that just as you have the right to withdraw your tender of Shares, the Fund has the right to cancel,
amend or postpone this offer at any time on or before the Expiration Date.

&nbsp;&nbsp;&nbsp;&nbsp;1. Background and Purpose of the Offer

The purpose of the Offer is to provide liquidity to Stockholders. Because there is no secondary trading market for Shares, the Board has determined, after consideration of various matters, that the Offer is in the best interests of Stockholders in order to provide liquidity for Shares as contemplated in the Prospectus. The Board intends to consider the continued desirability of the Fund making an offer to purchase Shares four times each year, but the Fund is not required to make any such offer.

The purchase of Shares pursuant to the Offer will have the effect of increasing the proportionate interest in the Fund of Stockholders who do not tender Shares. Stockholders who retain their Shares may be subject to increased risks that may possibly result from the reduction in the Fund's aggregate assets resulting from payment for the Shares tendered. These risks include the potential for greater volatility due to decreased diversification. A reduction in the aggregate assets of the Fund may result in Stockholders who do not tender Shares bearing higher costs to the extent that certain expenses borne by the Fund are relatively fixed and may not decrease if assets decline. These effects may be reduced or eliminated to the extent that additional purchases of Shares are made by new and existing investors from time to time, although there can be no assurances that such new or additional purchases will occur.

Shares that are tendered to the Fund in connection with the Offer, if accepted for repurchase, will be repurchased, resulting in a change in the income ratio and an increase in the expense ratios of Shares owned by Stockholders remaining in the Fund (assuming no further issuances of Shares).

&nbsp;&nbsp;&nbsp;&nbsp;2. Offer to Purchase and Price

The Fund will purchase, upon the terms and subject to the conditions of the Offer, up to 2,937,879 of those outstanding Shares that are properly tendered by, and not withdrawn (in accordance with Section 5 "Withdrawal Rights" below) before, the Expiration Date. The Fund has provided materials for the Offer to record holders as of November 26, 2025, on or about December 10, 2025.

The Fund reserves the right to extend, amend or cancel the Offer as described in Sections 3 and 7 below. The purchase price of a Share tendered will be its NAV as of the Valuation Date, payable as set forth in Section 6. The Fund reserves the right to adjust the Valuation Date to correspond with any extension of the Offer.

6 of 14

------

![LOGO](g949685g11g11.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;2. Offer to Purchase and Price *(continued)*

As of the close of business on November 26, 2025, there were approximately 32,733,181 Class I Shares, 7,146 Class D Shares, 26,015,453 Class U Shares, and 1,791 Class S Shares issued and outstanding, with a NAV per share of $23.53 for Class I Shares, $23.53 for Class D Shares, $23.53 for Class U Shares, and $23.53 for Class S Shares. Stockholders may obtain daily estimated NAV information until the Expiration Date of the Offer at <u>www.krest.reit.</u> The value of the Shares tendered by Stockholders likely will change between the most recent time NAV was calculated and communicated to you and the Valuation Date.

&nbsp;&nbsp;&nbsp;&nbsp;3. Amount of Tender

Subject to the limitations set forth below, Stockholders may tender all or a portion of their Shares. If you tender only a portion of your Shares, you must maintain a minimum account balance of at least $1,000 as of the Valuation Date. The Fund reserves the right to purchase all your Shares in the Fund if you tender less than all of your Shares and the number of Shares you tender would cause your account in the Fund to have a value lower than the required minimum balance. The Offer is being made to all Stockholders and is not conditioned on any minimum amount of Shares being tendered.

If less than 2,937,879 Shares are properly tendered pursuant to the Offer and not withdrawn, the Fund will, on the terms and subject to the conditions of the Offer, purchase all of the Shares so tendered unless the Fund elects to cancel or amend the Offer, or postpone acceptance of tenders made pursuant to the Offer, as provided in Section 7 "Certain Conditions of the Offer" below. If more than 2,937,879 Shares are duly tendered to the Fund before the expiration of the Offer and not withdrawn, pursuant to Section 5 "Withdrawal Rights" below, the Fund will accept Shares tendered on or before the Expiration Date for payment on a pro rata basis based on the number of tendered Shares with priority for repurchase requests in the case of the death or disability of a stockholder; provided that Fund reserves the right in its sole discretion to purchase additional outstanding Shares representing up to 2.0% of the aggregate NAV of the Fund's outstanding Shares without amending or extending the Offer as permitted by Rule 13e-4(f)(1) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The unaccepted portion of any tender of Shares made by a Stockholder pursuant to this Offer shall not be automatically carried forward or given priority in connection with any future tender offer made by the Fund, but any Stockholder that wishes to have the Fund repurchase Shares that were not accepted for repurchase in connection with this Offer may again tender those Shares in connection with, and subject to the terms and conditions of, any future tender offer made by the Fund.

&nbsp;&nbsp;&nbsp;&nbsp;4. Procedure for Tenders

Stockholders wishing to tender Shares pursuant to the Offer must complete and execute the Letter of Transmittal in accordance with the instructions on the first page of such Stockholder's Letter of Transmittal. The completed and executed Letter of Transmittal must be received by the specified agent by 4:00 p.m., Eastern Time, on the Expiration Date.

With respect to Stockholders that are required to submit their Letter of Transmittal to the Transfer Agent, Attention: KKR Democratized Access Vehicles, submissions may be made either by (a) mail at P.O. Box 219302, Kansas City MO 64121-9302 (regular mail), or 801 Pennsylvania Ave, Suite 219302, Kansas City, MO 64105-1307 (overnight mail), or (b) fax to (833) 674-0748, or (c) email to <u>KKRREDEEM.ai@sscinc.com.</u> The Fund recommends that all documents be submitted by certified mail, return receipt requested, or by fax. A Stockholder choosing to fax a Letter of Transmittal must also mail the original completed and executed Letter of Transmittal promptly thereafter.

If you would like to participate in the Offer, and your Shares are held through a financial intermediary, such as a financial adviser, broker/dealer, or other nominee (each, a "Financial Intermediary"), please ask your Financial Intermediary to submit a repurchase request for you. You may be charged a transaction fee for this service by your Financial Intermediary. Please consider any processing time that may be needed prior to the Expiration Date. Each intermediary may establish its own specific deadline for receipt of completed repurchase request materials from its clients.

7 of 14

------

![LOGO](g949685g11g11.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;4. Procedure for Tenders *(continued)*

Stockholders wishing to confirm receipt of a Letter of Transmittal may contact the agent specified in the instructions therein. ***The method of delivery of any documents is at the election and complete risk of the Stockholder tendering Shares, including, but not limited to, the failure to receive any Letter of Transmittal or other document submitted by facsimile transmission.*** All questions as to the validity, form, eligibility (including time of receipt) and acceptance of tenders will be determined by the Fund, in its sole discretion, and its determination shall be final and binding. The Fund reserves the absolute right to reject any or all tenders (i) determined by it not to be in appropriate form or (ii) for which the acceptance of, or payment for, would, in the opinion of counsel for the Fund, be unlawful. The Fund also reserves the absolute right to waive any of the conditions of the Offer or any defect in any tender with respect to any particular Shares or any particular Stockholder (including, without limitation, the conditions relating to the dates on which Shares must be tendered or withdrawn), and the Fund's interpretation of the terms and conditions of the Offer will be final and binding. Unless waived, any defects or irregularities in connection with tenders must be cured within such time as the Fund shall determine. Tenders will not be deemed to have been made until the defects or irregularities have been cured or waived. None of the Fund, the Board, the Adviser, or any of their agents is obligated to give notice of any defects or irregularities in tenders, nor shall any of them incur any liability for failure to give such notice.

&nbsp;&nbsp;&nbsp;&nbsp;5. Withdrawal Rights

Any Stockholder tendering Shares pursuant to this Offer may withdraw tendered Shares at any time before the Expiration Date or, if the Fund has not accepted such tendered Shares, after February 9, 2026. A form to use to give notice of withdrawal is enclosed with the Offer to Purchase. To be effective, any notice of withdrawal must be timely received by the agent specified in the instructions to the Notice of Withdrawal. If your Shares are held at a Financial Intermediary, you may withdraw your tendered Shares prior to the Expiration Date by submitting notice to your Financial Intermediary sufficiently in advance of the Expiration Date. In the event you decide to modify or withdraw your tender, you should provide your Financial Intermediary with sufficient notice prior to the Expiration Date. All questions as to the form and validity (including time of receipt) of notices of withdrawal will be determined by the Fund, in its sole discretion, and such determination shall be final and binding. Shares properly withdrawn shall not thereafter be deemed to be tendered for purposes of the Offer. However, withdrawn Shares may be re-tendered prior to the Expiration Date by following the procedures for tenders described above.

&nbsp;&nbsp;&nbsp;&nbsp;6. Purchases and Payment

For purposes of the Offer, the Fund will be deemed to have accepted Shares that are tendered if and when it gives written notice to the tendering Stockholder of its election to purchase such Shares.

If an Investor tenders Shares and the Fund purchases those Shares, the Fund will effect payment for those Shares in cash promptly after the Expiration Date.

The Fund does not expect to impose any charges on repurchases of Shares in the Fund.

Each Stockholder whose Shares (or portion thereof) have been accepted for repurchase will continue to be a Stockholder of the Fund until the Valuation Date (and thereafter if not all of its Shares are repurchased) and may exercise his or her voting rights with respect to the repurchased Shares (or portion thereof) until the Valuation Date.

A Stockholder who tenders some but not all of such Stockholder's Shares for repurchase will be required to maintain a minimum account balance of $1,000 in the Fund. Such minimum account balance requirement may be waived by the Fund, in its sole discretion. The Fund reserves the right to reduce the number of Shares to be repurchased from a Stockholder so that the required account balance is maintained.

8 of 14

------

![LOGO](g949685g11g11.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;6. Purchases and Payment *(continued)*

The Fund expects that the purchase price for Shares acquired pursuant to the Offer to Purchase will be derived from cash on hand (including cash received from investments in the Fund), borrowings and/or proceeds from the sale of portfolio holdings. Payment for repurchased shares may require the Fund to liquidate portfolio holdings earlier than our Adviser would otherwise have caused these holdings to be liquidated, potentially resulting in losses, and may increase our investment-related expenses as a result of higher portfolio turnover rates. The Fund intends to take measures, subject to policies as may be established by our Board of Directors, to attempt to avoid or minimize potential losses and expenses resulting from the repurchase of shares.

&nbsp;&nbsp;&nbsp;&nbsp;7. Certain Conditions of the Offer

The Fund reserves the right, at any time and from time to time, to extend the period of time during which the Offer is pending by notifying Stockholders of such extension. If the Fund elects to extend the tender period, the Valuation Date may occur on a later date than the date specified in this Offer to Purchase. During any such extension, all Shares previously tendered and not withdrawn will remain subject to the Offer. The Fund also reserves the right, at any time and from time to time, up to and including acceptance of tenders pursuant to the Offer, to: (a) cancel the Offer and in the event of such cancellation, not to purchase or pay for any Shares tendered pursuant to the Offer; (b) amend the Offer; or (c) postpone the acceptance of Shares tendered. If the Fund determines to amend the Offer or to postpone the acceptance of Shares tendered, it will, to the extent necessary, extend the period of time during which the Offer is open as provided above and will promptly notify Stockholders.

Please note that just as you have the opportunity to withdraw shares that you have tendered under certain circumstances, the Fund has the right to cancel, amend or postpone the Offer at any time before accepting tendered Shares. The Fund may cancel the Offer, amend the Offer or postpone the acceptance of tenders made pursuant to the Offer if: (a) the Fund would not be able to liquidate portfolio investments in a manner that is orderly and consistent with the Fund's investment objectives and policies in order to purchase Shares tendered pursuant to the Offer; (b) there is, in the Board's judgment, any (i) legal action or proceeding instituted or threatened challenging the Offer or that otherwise would have a material adverse effect on the Fund, (ii) declaration of a banking moratorium by Federal or state authorities or any suspension of payment by banks in the United States or New York State that is material to the Fund, (iii) limitation imposed by Federal or state authorities on the extension of credit by lending institutions, (iv) suspension of trading on any organized exchange or over-the-counter market where the Fund has a material investment, (v) commencement of war, armed hostilities or other international or national calamity directly or indirectly involving the United States that is material to the Fund, (vi) material decrease in the estimated NAV of the Fund from the estimated NAV of the Fund as of the commencement of the Offer, or (vii) other event or condition that would have a material adverse effect on the Fund or its Stockholders if Shares tendered pursuant to the Offer were purchased; or (c) the Independent Directors of the Fund determine that it is not in the best interest of the Fund to purchase Shares pursuant to the Offer. However, there can be no assurance that the Fund will exercise its right to extend, amend or cancel the Offer or to postpone acceptance of tenders pursuant to the Offer.

&nbsp;&nbsp;&nbsp;&nbsp;8. Certain Information About the Fund

The Fund is a non-diversified, closed-end management investment company registered under the 1940 Act and is organized as a Maryland corporation. The principal executive office of the Fund is located at 30 Hudson Yards, New York, New York 10001 and the telephone number is (212) 750-8300. Shares are not traded on any established trading market.

The Fund does not have any plans or proposals that relate to or would result in: (a) the acquisition by any person of additional Shares (other than the Fund's intention to accept purchases for Shares from time to time, the DRIP or otherwise in the discretion of the Fund) or the disposition of Shares (except for periodic discretionary solicitations of tender offers); (b) an extraordinary transaction, such as a merger, reorganization or liquidation, involving the Fund; (c) any material

9 of 14

------

![LOGO](g949685g11g11.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;8. Certain Information About the Fund *(continued)*

change in the present distribution policy or indebtedness or capitalization of the Fund; (d) any change in the identity of the investment adviser or Directors of the Fund, or in the management of the Fund including, but not limited to, any plans or proposals to change the number or the term of the Directors, to change any material term of the investment advisory arrangements with the Adviser; (e) a sale or transfer of a material amount of assets of the Fund (other than as the Directors determine may be necessary or appropriate to fund any portion of the purchase price for Shares acquired pursuant to this Offer to Purchase or in connection with the ordinary portfolio transactions of the Fund); (f) any other material change in the Fund's structure or business, including any plans or proposals to make any changes in its fundamental investment policy for which a vote would be required by Section 13 of the 1940 Act; or (g) any changes in the Articles of Incorporation, as amended, Bylaws, or Prospectus or other actions that may impede the acquisition of control of the Fund by any person.

Based on the number of Shares outstanding as of November 26, 2025**,** the following persons (the named individuals being the Directors and officers) own the number of Shares indicated in the below table:

---

| | | |
|:---|:---|:---|
| **Person** | **Shares** | **Percentage of the Fund's**<br> **Outstanding Shares** |
|  Adviser | 10954992.20 | 18.64% |
|  Ralph Rosenberg | 47439.66 | \* |
|  Fran Bermanzohn | 12723.91 | \* |
|  Joan Binstock | 15579.69 | \* |
|  James Kropp | 21907.73 | \* |
|  Susan Meaney | 11264.24 | \* |
|  Nicholas O'Neill |  | \* |
|  Megan Gaul |  | \* |
|  Julia Butler | 3935.50 | \* |
|  James Amler |  | \* |
|  Lori Hoffman |  | \* |
|  Doug Krupa |  | \* |
|  Matt Salem |  | \* |
|  \* Less than 1%. |  |  |

---

Based on information available to the Fund, none of the persons listed above intends to tender any of his or her Shares in the Offer.

Reference is made to Section 8 "Certain Information About the Fund" of the Offer to Repurchase, which is incorporated herein by reference. Other than the issuance of Shares by the Fund in the ordinary course of business, there have been no transactions in Shares effected during the past sixty (60) days by the Fund, the Adviser, or any Director or officer of the Fund, or any person controlling the Fund or the Adviser.

&nbsp;&nbsp;&nbsp;&nbsp;9. Shareholder Priority Plan and NAV Support Agreement

On June 4, 2024, KAA, an affiliate of the Adviser, contractually committed to the Fund to continue to hold approximately 7,732,436 of Support Shares, through June 1, 2027 and, to the extent necessary, contribute such shares to the Fund to support a NAV per share of $27.00 on June 1, 2027. If on June 1, 2027 the Fund's NAV per share is less than $27.00 per share for any share class, KAA will contribute to the Fund as many of the Support Shares as are required, up to the

10 of 14

------

![LOGO](g949685g11g11.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;9. Shareholder Priority Plan and NAV Support Agreement *(continued)*

maximum number of Support Shares, to reduce the number of outstanding shares and increase the NAV per share for each class of the Fund's shares up to $27.00 per share. If the Fund's NAV per share for any class on June 1, 2027 is less than $27.00 per share and the contribution of all of the Support Shares is not sufficient to cause the NAV per share for each class to equal $27.00 per share, KAA will contribute all such Support Shares to support the Fund's NAV per share on such date. While the Shareholder Priority Plan is a contractual obligation to support the Fund's NAV per share, there is no guarantee that the contribution of the Support Shares will be sufficient to achieve a $27.00 per share NAV on June 1, 2027. For the avoidance of doubt, KAA is not obligated to contribute any of the Support Shares prior to June 1, 2027, and KAA is not obligated to contribute any of the Support Shares if the NAV per share for each class equals or exceeds $27.00 per share on June 1, 2027. All Fund shareholders on June 1, 2027 will benefit from this agreement. Existing shareholders do not need to take any action to take advantage of this opportunity.

&nbsp;&nbsp;&nbsp;&nbsp;10. Full Tender by DRIP Participants

If you are a participant in the DRIP, in the event you elect to tender your Shares in full, your participation in the DRIP will be automatically terminated as of the applicable Expiration Date and any distributions due but not yet paid as of such date will be paid in cash on the scheduled distribution payment date.

&nbsp;&nbsp;&nbsp;&nbsp;11. Certain Federal Income Tax Consequences

The following summary describes certain of the material U.S. federal income tax consequences relating to the purchase of Shares by the Fund from Stockholders pursuant to the Offer. Except where noted, this summary deals only with Shares held as a capital asset and does not deal with special situations, such as those of dealers in securities or currencies, financial institutions, regulated investment companies, tax-exempt entities, insurance companies, persons holding Shares as a part of a hedging, integrated, conversion or constructive sale transaction or a straddle, traders in securities that elect to use a mark-to-market method of accounting for their securities holdings, persons liable for alternative minimum tax, persons who are "foreign governments" within the meaning of Section 892 of the Internal Revenue Code of 1986, as amended (the "Code"), investors in pass-through entities or U.S. holders of Shares whose "functional currency" is not the U.S. dollar. Furthermore, the discussion below is based upon the provisions of the Code and regulations, rulings and judicial decisions thereunder as of the date hereof, and such authorities may be repealed, revoked or modified, possibly with retroactive effect, so as to result in U.S. federal income tax consequences different from those discussed below. No ruling on the U.S. federal, state, or local tax considerations relevant to the purchase of Shares by the Fund has been requested from the IRS or other tax authority. No assurance can be given that the IRS would not assert, or that a court would not sustain, a position contrary to any of the tax consequences described below. The summary is also based upon the assumption that we and our subsidiaries and affiliated entities will operate in accordance with our and their applicable organizational documents.

The U.S. federal income tax treatment of holders of our Shares depends in some instances on determinations of fact and interpretations of complex provisions of U.S. federal income tax law for which no clear precedent or authority may be available. In addition, the tax consequences to any particular Stockholder of holding Shares will depend on the Stockholder's particular tax circumstances. You are urged to consult your own tax advisors concerning the U.S. federal income tax consequences in light of your particular situation as well as consequences arising under the laws of any other taxing jurisdiction.

As used in the remainder of this discussion, the term "U.S. Stockholder" refers to a Stockholder that is for U.S. federal income tax purposes (i) a citizen or resident of the United States, (ii) a corporation (or an entity treated as a corporation for U.S. federal income tax purposes) created or organized in or under the laws of the United States, any State thereof or the District of Columbia, (iii) an estate the income of which is subject to U.S. federal income taxation regardless of its

11 of 14

------

![LOGO](g949685g11g11.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;11. Certain Federal Income Tax Consequences *(continued)*

source; or (iv) a trust if it (x) is subject to the primary supervision of a court within the United States and one or more U.S. persons have the authority to control all substantial decisions of the trust or (y) has a valid election in effect under applicable Treasury regulations to be treated as a U.S. person.

If a partnership (or an entity treated as a partnership for U.S. federal income tax purposes) holds Shares, the tax treatment of a partner will generally depend upon the status of the partner and the activities of the partnership. If you are a partner of a partnership holding Shares, you should consult your advisors.

A "Non-U.S. Stockholder" is a beneficial owner of Shares that is neither a U.S. holder nor a partnership (or an entity treated as a partnership for U.S. federal income tax purposes). Except for the discussion under "Non-U.S. Stockholders," the following discussion is limited to U.S. Stockholders.

For more detailed information regarding tax considerations applicable to a purchase of Shares by the Fund pursuant to the Offer, and ownership of Shares of the Fund in general, see the Fund's Prospectus.

**U.S. Stockholders.** An exchange of Shares for cash in the Offer will be a taxable transaction for U.S. federal income tax purposes. As a consequence of the exchange, a tendering U.S. Stockholder will, depending on such Stockholder's particular circumstances, be treated either as recognizing gain or loss from the disposition of the Shares or as receiving a dividend distribution from the Fund. Under Section 302(b) of the Code, a sale of Shares pursuant to the Offer generally will be treated as a sale or exchange if the receipt of cash by the Stockholder: (a) results in a complete termination of the Stockholder's interest in the Fund, (b) results in a substantially disproportionate redemption with respect to the Stockholder, or (c) is not essentially equivalent to a dividend with respect to the Stockholder. In determining whether any of these tests have been met, Shares actually owned, as well as Shares considered to be owned by the Stockholder by reason of certain constructive ownership rules set forth in Section 318 of the Code, generally must be taken into account. The sale of Shares pursuant to the Offer generally will result in a "substantially disproportionate" redemption with respect to a Stockholder if the percentage of the Fund's then outstanding voting stock owned by the Stockholder immediately after the sale is less than 80% of the percentage of the Fund's voting stock owned by the Stockholder determined immediately before the sale. The sale of Shares pursuant to the Offer generally will be treated as "not essentially equivalent to a dividend" with respect to a Stockholder if the reduction in the Stockholder's proportionate interest in the Fund's stock as a result of the Fund's purchase of Shares constitutes a "meaningful reduction" of the Stockholder's interest. If any of the above three tests for sale or exchange treatment is met, a U.S. Stockholder will recognize gain or loss equal to the difference between the price paid by the Fund for the Shares purchased in the Offer and the Stockholder's adjusted basis in such Shares. If such Shares are held as a capital asset, the gain or loss will be capital gain or loss. Gain or loss will be determined separately for blocks of Shares acquired at different times or at different prices. The maximum tax rate applicable to capital gains recognized by individuals and other non-corporate taxpayers is (i) the same as the applicable ordinary income rate for capital assets held for one year or less or (ii) 20% for capital assets held for more than one year. The deductibility of capital losses is subject to limitations.

If the requirements of Section 302(b) of the Code are not met, amounts received by a Stockholder who sells Shares pursuant to the Offer will be taxable to the Stockholder as a dividend to the extent of such Stockholder's allocable share of the Fund's current or accumulated earnings and profits. To the extent that amounts received exceed such Stockholder's allocable share of the Fund's current and accumulated earnings and profits for a taxable year, the distribution will first be treated as a non-taxable return of capital, causing a reduction in the adjusted basis of such Stockholder's Shares, and any amounts in excess of the Stockholder's adjusted basis will constitute taxable gain. Any remaining adjusted basis in the Shares tendered to the Fund will be transferred to any remaining Shares held by such Stockholder.

If the payment for any purchase of Shares pursuant to the Offer is treated as a taxable dividend to the selling Stockholder rather than as an exchange, the other Stockholders, including the non-tendering U.S. Stockholders, could be deemed to have received taxable stock distributions under certain circumstances. Stockholders are urged to consult their own tax advisors regarding the possibility of deemed distributions resulting from the purchase of Shares pursuant to the Offer.

12 of 14

------

![LOGO](g949685g11g11.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;11. Certain Federal Income Tax Consequences *(continued)*

**Non-U.S. Stockholders.** The Transfer Agent or applicable withholding agent may withhold U.S. federal income taxes equal to 30% of the gross payments payable to a Non-U.S. Stockholder or his or her agent unless the Transfer Agent or applicable withholding agent determines that a reduced rate of withholding is available pursuant to a tax treaty or that an exemption from withholding is applicable because such gross proceeds are effectively connected with the conduct of a trade or business within the U.S. In order to obtain a reduced rate of withholding pursuant to a tax treaty, a Non-U.S. Stockholder must deliver to the Transfer Agent or applicable withholding agent before the payment a properly completed and executed IRS Form W-8BEN (for individuals) or Form W-8BEN-E (for entities). In order to obtain an exemption from withholding on the grounds that the gross proceeds paid pursuant to the Offer are effectively connected with the conduct of a trade or business within the U.S., a Non-U.S. Stockholder must deliver to the Transfer Agent or applicable withholding agent a properly completed and executed IRS Form W-8ECI. The Transfer Agent or applicable withholding agent will determine a Stockholder's status as a Non-U.S. Stockholder and eligibility for a reduced rate of, or exemption from, withholding by reference to any outstanding certificates or statements concerning eligibility for a reduced rate of, or exemption from, withholding (e.g., IRS Forms W-8BEN, W-8BEN-E or W-8ECI) unless facts and circumstances indicate that such reliance is not warranted. A Non-U.S. Stockholder may be eligible to obtain a refund of all or a portion of any tax withheld if such Non-U.S. Stockholder meets one of the "complete termination," "substantially disproportionate" or "not essentially equivalent to a dividend" tests described above or is otherwise able to establish that no tax or a reduced amount of tax is due. Backup withholding (discussed below) generally will not apply to amounts subject to the 30% or a treaty-reduced rate of withholding. Non-U.S. Stockholders are urged to consult their own tax advisors regarding the application of U.S. federal income tax withholding, including eligibility for a withholding tax reduction or exemption, and the refund procedure.

If the payment for any purchase of Shares pursuant to the Offer is treated as a taxable dividend to the selling Stockholder rather than as an exchange, the other Stockholders, including the non-tendering Non-U.S. Stockholders, could be deemed to have received taxable stock distributions under certain circumstances. Stockholders are urged to consult their own tax advisors regarding the possibility of deemed distributions resulting from the purchase of Shares pursuant to the Offer.

In addition, a Non-U.S. Stockholder (other than an individual) may be subject to a 30% withholding tax under FATCA unless such Non-U.S. Stockholder establishes an exemption from such withholding tax under FATCA, typically on IRS Form W-8BEN-E. If the Transfer Agent or applicable withholding agent withholds any amounts under FATCA, such amounts will be credited against any withholding due for U.S. federal income tax.

For more detailed information regarding tax considerations applicable to a purchase of Shares by the Fund from a Non-U.S. Stockholder pursuant to the Offer, including considerations relating to the Foreign Investment in Real Property Tax Act of 1980, as amended, see the Fund's Prospectus.

**Backup Federal Income Tax Withholding.** Backup withholding tax will be imposed on the gross proceeds paid to a tendering U.S. Stockholder unless the U.S. Stockholder provides to the Transfer Agent or applicable withholding agent a correct U.S. taxpayer identification number, certifies that such U.S. Stockholder is exempt from backup withholding and otherwise complies with applicable requirements of the backup withholding rules. Therefore, each tendering U.S. Stockholder must complete and sign an Internal Revenue Service ("IRS") Form W-9 prior to the payment so as to provide the information and certification necessary to avoid backup withholding, unless such U.S. Stockholder otherwise establishes to the satisfaction of the Transfer Agent or applicable withholding agent that such U.S. Stockholder is not subject to backup withholding. Certain U.S. Stockholders (including, among others, most corporations) are not subject to these backup withholding requirements. In addition, Non-U.S. Stockholders are not subject to these withholding requirements. In order for a Non-U.S. Stockholder to qualify as an exempt recipient, that Non-U.S. Stockholder generally must submit an applicable IRS Form W-8 (generally, an IRS Form W-8BEN, W-8BEN-E or W-8ECI).

**The tax discussion set forth above is included for general information only. Each Stockholder is urged to consult his or her own tax advisor to determine the particular tax consequences to him or her of the Offer, including the applicability and effect of state, local and foreign tax laws.**

13 of 14

------

![LOGO](g949685g11g11.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;12. Miscellaneous

The Offer is not being made to, nor will tenders be accepted from, Stockholders in any jurisdiction in which the Offer or its acceptance would not comply with the securities or Blue Sky laws of such jurisdiction. The Fund is not aware of any jurisdiction in which the Offer or tenders pursuant thereto would not be in compliance with the laws of such jurisdiction. However, the Fund reserves the right to exclude Stockholders from the Offer in any jurisdiction in which it is asserted that the Offer cannot lawfully be made. The Fund believes such exclusion is permissible under applicable laws and regulations, provided the Fund makes a good faith effort to comply with any state law deemed applicable to the Offer.

The Fund has filed an Issuer Tender Offer Statement on Schedule TO with the Securities and Exchange Commission (the "SEC"), which includes certain information relating to the Offer summarized herein. A free copy of such statement may be obtained from the Fund at <u>www.krest.reit</u>, by contacting the Transfer Agent at (855) 844-8655, or from the SEC's internet web site, <u>http://www.sec.gov</u>.

&nbsp;&nbsp;&nbsp;&nbsp;13. Financial Statements

Financial statements have not been included herein because the consideration offered to shareholders consists solely of cash; the Offer is not subject to any financing condition; and the Company is a public reporting company under Section 13(a) of the Exchange Act, and files its reports electronically on the EDGAR system.

Reports and other information about the Company are available on the EDGAR Database on the SEC's Internet site (*<u>www.sec.gov</u>*), and copies of this information may be obtained, after paying a duplicating fee, by electronic request at the following E-mail address: <u>publicinfo@sec.gov</u>.

14 of 14

------

---

| | | |
|:---|:---|:---|
| <br> ![LOGO](g949685g11g11.jpg) <br>| ![LOGO](g949685g08g08.jpg) | [ |

---

c/o KKR Registered Advisor LLC.

30 Hudson Yards, New York, New York 10001

*Offer to Purchase Up to 2,937,879 Shares of Common Stock Dated December 10, 2025* 

*For Stockholders through Merrill, Lynch, Pierce, Fenner & Smith, Inc. ("Merrill")* 

*The Offer and Withdrawal Rights Will Expire at 4:00 p.m., Eastern Time, on January 9, 2026, Unless the Offer is Extended* 

To the Stockholders through Merrill of KKR Real Estate Select Trust Inc.:

Subject to the terms and conditions set forth in this offer to purchase ("Offer to Purchase") and the related Letter of Transmittal (which together with the Offer to Purchase constitutes the "Offer"), KKR Real Estate Select Trust Inc., a non-diversified, closed-end management investment company registered under the Investment Company Act of 1940, as amended (the "1940 Act") and organized as a Maryland corporation (the "Fund"), is offering to purchase up to 2,937,879 of its outstanding shares of common stock (including Class I shares of common stock, Class D shares of common stock, Class S shares of common stock and Class U shares of common stock, the "Shares") pursuant to tenders by stockholders of the Fund ("Stockholders") at a price equal to the net asset value ("NAV") per Share as of January 9, 2026 or a later date determined by the Fund if the Offer is extended (the "Valuation Date"). This Offer is currently scheduled to expire at 4:00 p.m., Eastern Time, on January 9, 2026 (the "Expiration Date"), but the Fund may extend this date; if it does, the Valuation Date may be changed. This Offer is being made to all Stockholders of the Fund and is not conditioned on any minimum amount of Shares being tendered, but is subject to certain conditions described below. Shares are not traded on any established trading market**. Because you hold your shares through Merrill, if you wish to tender a portion or all of your Shares during this repurchase offer period, you must contact your investment professional and request to tender your Shares no later than 11:59 pm Eastern Time January 8, 2026 (the "Merrill Repurchase Deadline") to allow for order processing. Merrill will tender your Shares to the Fund on your behalf. Do not submit repurchase requests directly to the Fund or its transfer agent as they will not be honored.**

**The Merrill Repurchase Deadline will be strictly observed. If Merrill is unable or fails to submit your request to the Fund in a timely manner, or if you fail to communicate your request to tender your Shares to your investment professional by the Merrill Repurchase Deadline, you will be unable to tender your Shares to the Fund until a subsequent repurchase offer, and your request for that offer would need to be resubmitted.**

Stockholders should realize that the value of the Shares tendered in this Offer will likely change between the most recent time NAV was calculated and communicated to them and the Valuation Date (the relevant date for determining the value of the Shares tendered to the Fund for purposes of calculating the purchase price of such Shares) and such change could be material. The Fund generally determines the NAV of the Shares daily as of the close of regular trading on the New York Stock Exchange (normally, 4:00 p.m. Eastern Time). The most recently calculated NAV for each class of the Shares can be found by going to <u>www.krest.reit</u>.

1 of 13

------

![LOGO](g949685g11g11.jpg)

On June 4, 2024, KKR Alternative Assets LLC ("KAA"), an affiliate of KKR Registered Advisor LLC, the Fund's investment adviser (the "Adviser"), contractually committed to the Fund to continue to hold approximately 7,732,436 of Class I Shares currently owned by KAA, representing approximately $200 million based on the Fund's NAV as of May 28, 2024 (the "Support Shares"), through June 1, 2027 and, to the extent necessary, contribute such shares to the Fund to support a NAV per share of $27.00 on June 1, 2027. If on June 1, 2027 the Fund's NAV per share is less than $27.00 per share for any share class, KAA will contribute to the Fund as many of the Support Shares as are required, up to the maximum number of Support Shares, to reduce the number of outstanding shares and increase the NAV per share for each class of the Fund's shares up to $27.00 per share (the "Shareholder Priority Plan"). If the Fund's NAV per share for any class on June 1, 2027 is less than $27.00 per share and the contribution of all of the Support Shares is not sufficient to cause the NAV per share for each class to equal $27.00 per share, KAA will contribute all such Support Shares to support the Fund's NAV per share on such date. While the Shareholder Priority Plan is a contractual obligation to support the Fund's NAV per share, there is no guarantee that the contribution of the Support Shares will be sufficient to achieve a $27.00 per share NAV on June 1, 2027. For the avoidance of doubt, KAA is not obligated to contribute any of the Support Shares prior to June 1, 2027, and KAA is not obligated to contribute any of the Support Shares if the NAV per share for each class equals or exceeds $27.00 per share on June 1, 2027.

Stockholders desiring to tender all or any portion of their Shares in accordance with the terms of the Offer should complete and sign the attached Letter of Transmittal and mail or fax it to the Fund's transfer agent, SS&C Global Investor & Distribution Solutions, Inc. (the "Transfer Agent"), or the Stockholder's financial advisor, as applicable, in the manner provided for in the Letter of Transmittal and set forth in Section 4 "Procedure for Tenders" below.

**IMPORTANT** 

The Fund makes no recommendation to any Stockholder as to whether to tender or refrain from tendering Shares. Stockholders must make their own decisions whether to tender Shares and, if so, the portion of their Shares to tender.

Because each Stockholder's investment decision is a personal one, based on its financial circumstances, no person has been authorized to make any recommendation on behalf of the Fund as to whether Stockholders should tender Shares pursuant to the Offer. No person has been authorized to give any information or to make any representations in connection with the Offer other than those contained herein or in the Letter of Transmittal. If given or made, such recommendation and such information and representations must not be relied on as having been authorized by the Fund.

This transaction has not been approved or disapproved by the Securities and Exchange Commission or the Commodity Futures Trading Commission nor has the Securities and Exchange Commission, the Commodity Futures Trading Commission, or any state securities commission passed on the fairness or merits of such transaction or on the accuracy or adequacy of the information contained in this document. Any representation to the contrary is unlawful.

2 of 13

------

![LOGO](g949685g11g11.jpg)

 **Table Of Contents** 

---

| | | |
|:---|:---|:---|
|  **[Summary Term Sheet](#mlotp949685_1)** | **[Summary Term Sheet](#mlotp949685_1)** | **4** |
| **1.** | **[Background and Purpose of the Offer](#mlotp949685_2)** | **5** |
| **2.** | **[Offer to Purchase and Price](#mlotp949685_3)** | **5** |
| **3.** | **[Amount of Tender](#mlotp949685_4)** | **6** |
| **4.** | **[Procedure for Tenders](#mlotp949685_5)** | **6** |
| **5.** | **[Withdrawal Rights](#mlotp949685_6)** | **7** |
| **6.** | **[Purchases and Payment](#mlotp949685_7)** | **7** |
| **7.** | **[Certain Conditions of the Offer](#mlotp949685_8)** | **8** |
| **8.** | **[Certain Information About the Fund](#mlotp949685_9)** | **8** |
| **9.** | **[Shareholder Priority Plan and NAV Support Agreement](#mlotp949685_10)** | **9** |
| **10.** | **[Full Tender by DRIP Participants](#mlotp949685_11)** | **10** |
| **11.** | **[Certain Federal Income Tax Consequences](#mlotp949685_12)** | **10** |
| **12.** | **[Miscellaneous](#mlotp949685_13)** | **12** |
| **13.** | **[Financial Statements](#mlotp949685_14)** | **13** |

---

3 of 13

------

![LOGO](g949685g11g11.jpg)

**Summary Term Sheet** 

**This is a summary of the features of the Offer. To understand the Offer fully and for a more complete discussion of the terms and conditions of the Offer, you should read carefully this entire Offer to Purchase and the related Letter of Transmittal.** 

• As disclosed in the Fund's prospectus dated April 23, 2025 as amended and/or supplemented from time to time
("Prospectus"), the Fund may from time to time offer to repurchase a portion of its outstanding Shares pursuant to written tenders by Stockholders. Accordingly, the Fund is offering to purchase up to 2,937,879 Shares at a price equal to
their NAV (that is, the value of the Fund's total assets minus its total liabilities, divided by outstanding Shares) determined as of January 9, 2026 or such later date as may be determined by the Fund if the Offer is extended (the
"Valuation Date"). The Shares subject to the Offer represent approximately **5%** of the outstanding Shares as of November 26, 2025. The Offer, which begins on December 10, 2025, will remain open until 4:00 p.m., Eastern
Time, on January 9, 2026 (the "Expiration Date"). The Fund reserves the right to adjust the Valuation Date to correspond to any extension of the Offer.

• Stockholders may tender all or a portion of their Shares.

• If an Investor tenders Shares and the Fund purchases those Shares, the Fund will effect payment for those Shares in cash
promptly after the Expiration Date.

• The Fund does not expect to impose any charges on repurchases of Shares in the Fund.

• If you tender only a portion of your Shares, you must maintain a minimum account balance of at least $1,000 as of the
Valuation Date. The Fund reserves the right to purchase all your Shares in the Fund if you tender less than all of your Shares and the number of Shares you tender would cause your account in the Fund to have a value lower than the required minimum
balance. The Offer is being made to all Stockholders and is not conditioned on any minimum amount of Shares being tendered.

• If you are a participant in the Fund's distribution reinvestment plan ("DRIP"), in the event that you
elect to tender your Shares in full, your participation in the DRIP will be automatically terminated as of the applicable Expiration Date, and any distributions due but not yet paid as of such date will be paid in cash on the scheduled dividend
payment date.

• If the Fund accepts the tender of any of your Shares, your proceeds will be funded from one or more of the following
sources: cash on hand (including cash received from investments in the Fund), borrowings and/or proceeds from the sale of portfolio holdings.

• Additional repurchases will be made at such times and on such terms as may be determined by the Board of Directors of the
Fund (the "Board"). The Adviser expects that it will generally recommend to the Board that the Fund offer to repurchase a portion of its outstanding Shares four times each year, effective on or about January 15, April 15,
July 15 and October 15, but the Fund is not required to make any such offer.

• Following this summary is a formal notice of the Offer, which remains open until and through the Expiration Date, unless
extended. If you elect to tender your Shares, you have the right to change your mind and withdraw your tendered Shares at any time until 11:59 p.m. Eastern Time on January 8, 2026 (the "Merrill Repurchase Deadline") or, if such
tendered Shares have not been accepted by the Fund, at any time after February 9, 2026. If you would like to tender your Shares, you must contact your investment professional and request to tender your Shares no later than the Merrill
Repurchase Deadline to allow for order processing. Merrill will tender your Shares to the Fund on your behalf. Do not submit tender requests directly to the Fund or its transfer agent as they will not be honored.

• The value of your Shares will likely change between the most recent time the NAV was calculated and communicated to you and
the Valuation Date (the date when the value of your investment will be determined for purposes of calculating the purchase price of your Shares). If you would like to obtain the estimated NAV of your Shares, visit the Fund's website at <u>www.krest.reit</u>.

• On June 4, 2024, KAA, an affiliate of the Adviser, contractually committed to the Fund to continue to hold
approximately 7,732,436 of Support Shares, through June 1, 2027 and, to the extent necessary, contribute such shares

4 of 13

------

![LOGO](g949685g11g11.jpg)

**Summary Term Sheet** *(continued)*

to the Fund to support a NAV per share of $27.00 on June 1, 2027. If on June 1, 2027 the Fund's NAV per share is less than $27.00 per share for any share class, KAA will contribute to the Fund as many of the Support Shares as are required, up to the maximum number of Support Shares, to reduce the number of outstanding shares and increase the NAV per share for each class of the Fund's shares up to $27.00 per share. If the Fund's NAV per share for any class on June 1, 2027 is less than $27.00 per share and the contribution of all of the Support Shares is not sufficient to cause the NAV per share for each class to equal $27.00 per share, KAA will contribute all such Support Shares to support the Fund's NAV per share on such date.

• Please note that just as you have the right to withdraw your tender of Shares, the Fund has the right to cancel, amend or
postpone this offer at any time on or before the Expiration Date.

&nbsp;&nbsp;&nbsp;&nbsp;1. Background and Purpose of the Offer

The purpose of the Offer is to provide liquidity to Stockholders. Because there is no secondary trading market for Shares, the Board has determined, after consideration of various matters, that the Offer is in the best interests of Stockholders in order to provide liquidity for Shares as contemplated in the Prospectus. The Board intends to consider the continued desirability of the Fund making an offer to purchase Shares four times each year, but the Fund is not required to make any such offer.

The purchase of Shares pursuant to the Offer will have the effect of increasing the proportionate interest in the Fund of Stockholders who do not tender Shares. Stockholders who retain their Shares may be subject to increased risks that may possibly result from the reduction in the Fund's aggregate assets resulting from payment for the Shares tendered. These risks include the potential for greater volatility due to decreased diversification. A reduction in the aggregate assets of the Fund may result in Stockholders who do not tender Shares bearing higher costs to the extent that certain expenses borne by the Fund are relatively fixed and may not decrease if assets decline. These effects may be reduced or eliminated to the extent that additional purchases of Shares are made by new and existing investors from time to time, although there can be no assurances that such new or additional purchases will occur.

Shares that are tendered to the Fund in connection with the Offer, if accepted for repurchase, will be repurchased, resulting in a change in the income ratio and an increase in the expense ratios of Shares owned by Stockholders remaining in the Fund (assuming no further issuances of Shares).

&nbsp;&nbsp;&nbsp;&nbsp;2. Offer to Purchase and Price

The Fund will purchase, upon the terms and subject to the conditions of the Offer, up to 2,937,879 of those outstanding Shares that are properly tendered by, and not withdrawn (in accordance with Section 5 "Withdrawal Rights" below) before, the Expiration Date. The Fund has provided materials for the Offer to record holders as of November 26, 2025, on or about December 10, 2025.

The Fund reserves the right to extend, amend or cancel the Offer as described in Sections 3 and 7 below.

The purchase price of a Share tendered will be its NAV as of the Valuation Date, payable as set forth in Section 6. The Fund reserves the right to adjust the Valuation Date to correspond with any extension of the Offer.

As of the close of business on November 26, 2025, there were approximately 32,733,181 Class I Shares, 7,146 Class D Shares, 26,015,453 Class U Shares, and 1,791 Class S Shares issued and outstanding, with a NAV per share of $23.53 for

5 of 13

------

![LOGO](g949685g11g11.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;2. Offer to Purchase and Price *(continued)*

Class I Shares, $23.53 for Class D Shares, $23.53 for Class U Shares, and $23.53 for Class S Shares. Stockholders may obtain daily estimated NAV information until the Expiration Date of the Offer at <u>www.krest.reit</u>. The value of the Shares tendered by Stockholders likely will change between the most recent time NAV was calculated and communicated to you and the Valuation Date.

You must decide whether to tender Shares by the Merrill Repurchase Deadline, which is 11:59 p.m. on the business day prior to the Expiration Date, but the NAV at which the Fund will repurchase each class of the Shares will not be calculated until the Valuation Date. The NAV can fluctuate, and the NAV on the Valuation Date could be lower or higher than the NAV on the date you submit your repurchase request. Please visit <u>www.krest.reit</u> for the Fund's most current NAV per share.

&nbsp;&nbsp;&nbsp;&nbsp;3. Amount of Tender

Subject to the limitations set forth below, Stockholders may tender all or a portion of their Shares. If you tender only a portion of your Shares, you must maintain a minimum account balance of at least $1,000 as of the Valuation Date. The Fund reserves the right to purchase all your Shares in the Fund if you tender less than all of your Shares and the number of Shares you tender would cause your account in the Fund to have a value lower than the required minimum balance. The Offer is being made to all Stockholders and is not conditioned on any minimum amount of Shares being tendered.

If less than 2,937,879 Shares are properly tendered pursuant to the Offer and not withdrawn, the Fund will, on the terms and subject to the conditions of the Offer, purchase all of the Shares so tendered unless the Fund elects to cancel or amend the Offer, or postpone acceptance of tenders made pursuant to the Offer, as provided in Section 7 "Certain Conditions of the Offer" below. If more than 2,937,879 Shares are duly tendered to the Fund before the expiration of the Offer and not withdrawn, pursuant to Section 5 "Withdrawal Rights" below, the Fund will accept Shares tendered on or before the Expiration Date for payment on a pro rata basis based on the number of tendered Shares with priority for repurchase requests in the case of the death or disability of a stockholder; provided that Fund reserves the right in its sole discretion to purchase additional outstanding Shares representing up to 2.0% of the aggregate NAV of the Fund's outstanding Shares without amending or extending the Offer as permitted by Rule 13e-4(f)(1) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). The unaccepted portion of any tender of Shares made by a Stockholder pursuant to this Offer shall not be automatically carried forward or given priority in connection with any future tender offer made by the Fund, but any Stockholder that wishes to have the Fund repurchase Shares that were not accepted for repurchase in connection with this Offer may again tender those Shares in connection with, and subject to the terms and conditions of, any future tender offer made by the Fund.

&nbsp;&nbsp;&nbsp;&nbsp;4. Procedure for Tenders

For Stockholders holding their stock directly, all requests to tender Shares pursuant to this Offer must be received in properly completed form by the Fund at 4:00 p.m. Eastern Time (the "NYSE Close") on the Expiration Date. Because you hold your Shares through Merrill, if you wish to tender a portion or all of your Shares during this offer period, you must contact your investment professional and request to tender your Shares no later than 11:59 p.m. Eastern Time on January 8, 2026 (the "Merrill Repurchase Deadline") to allow for order processing. Merrill will tender your Shares to the Fund on your behalf. Do not submit repurchase requests directly to the Fund or its transfer agent as they will not be honored.

6 of 13

------

![LOGO](g949685g11g11.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;4. Procedure for Tenders *(continued)*

You may withdraw or change your request to tender your Shares at any point prior to the Merrill Repurchase Deadline as described in paragraph 5 below.

**If you are not a Merrill client and wish to sell shares in response to this offer, you must ask your intermediary sufficiently in advance of the Expiration Date to submit a request for you (if you hold shares through an intermediary) or you must submit a request directly to the Fund's transfer agent using the Transmittal Letter– For Accounts Held Directly with KKR Real Estate Select Trust Inc. prior to the Expiration Date (if you hold shares directly). You may not receive another notification related to the current offer in addition to this one.**

&nbsp;&nbsp;&nbsp;&nbsp;5. Withdrawal Rights

Any Stockholder requesting to tender shares in this Offer may modify or withdraw their request at any time prior to the Merrill Repurchase Deadline, or, if the Fund has not accepted such tendered Shares, after February 9, 2026, by notifying their investment professional.

&nbsp;&nbsp;&nbsp;&nbsp;6. Purchases and Payment

For purposes of the Offer, the Fund will be deemed to have accepted Shares that are tendered if and when it gives written notice to the tendering Stockholder of its election to purchase such Shares.

If an Investor tenders Shares and the Fund purchases those Shares, the Fund will effect payment for those Shares in cash promptly after the Expiration Date.

The Fund does not expect to impose any charges on repurchases of Shares in the Fund.

Each Stockholder whose Shares (or portion thereof) have been accepted for repurchase will continue to be a Stockholder of the Fund until the Valuation Date (and thereafter if not all of its Shares are repurchased) and may exercise his or her voting rights with respect to the repurchased Shares (or portion thereof) until the Valuation Date.

A Stockholder who tenders some but not all of such Stockholder's Shares for repurchase will be required to maintain a minimum account balance of $1,000 in the Fund. Such minimum account balance requirement may be waived by the Fund, in its sole discretion. The Fund reserves the right to reduce the number of Shares to be repurchased from a Stockholder so that the required account balance is maintained.

The Fund expects that the purchase price for Shares acquired pursuant to the Offer to Purchase will be derived from cash on hand (including cash received from investments in the Fund), borrowings and/or proceeds from the sale of portfolio holdings. Payment for repurchased shares may require the Fund to liquidate portfolio holdings earlier than our Adviser would otherwise have caused these holdings to be liquidated, potentially resulting in losses, and may increase our investment-related expenses as a result of higher portfolio turnover rates. The Fund intends to take measures, subject to policies as may be established by our Board of Directors, to attempt to avoid or minimize potential losses and expenses resulting from the repurchase of shares.

7 of 13

------

![LOGO](g949685g11g11.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;7. Certain Conditions of the Offer

The Fund reserves the right, at any time and from time to time, to extend the period of time during which the Offer is pending by notifying Stockholders of such extension. If the Fund elects to extend the tender period, the Valuation Date may occur on a later date than the date specified in this Offer to Purchase. During any such extension, all Shares previously tendered and not withdrawn will remain subject to the Offer. The Fund also reserves the right, at any time and from time to time, up to and including acceptance of tenders pursuant to the Offer, to: (a) cancel the Offer and in the event of such cancellation, not to purchase or pay for any Shares tendered pursuant to the Offer; (b) amend the Offer; or (c) postpone the acceptance of Shares tendered. If the Fund determines to amend the Offer or to postpone the acceptance of Shares tendered, it will, to the extent necessary, extend the period of time during which the Offer is open as provided above and will promptly notify Stockholders.

Please note that just as you have the opportunity to withdraw shares that you have tendered under certain circumstances, the Fund has the right to cancel, amend or postpone the Offer at any time before accepting tendered Shares. The Fund may cancel the Offer, amend the Offer or postpone the acceptance of tenders made pursuant to the Offer if: (a) the Fund would not be able to liquidate portfolio investments in a manner that is orderly and consistent with the Fund's investment objectives and policies in order to purchase Shares tendered pursuant to the Offer; (b) there is, in the Board's judgment, any (i) legal action or proceeding instituted or threatened challenging the Offer or that otherwise would have a material adverse effect on the Fund, (ii) declaration of a banking moratorium by Federal or state authorities or any suspension of payment by banks in the United States or New York State that is material to the Fund, (iii) limitation imposed by Federal or state authorities on the extension of credit by lending institutions, (iv) suspension of trading on any organized exchange or over-the-counter market where the Fund has a material investment, (v) commencement of war, armed hostilities or other international or national calamity directly or indirectly involving the United States that is material to the Fund, (vi) material decrease in the estimated NAV of the Fund from the estimated NAV of the Fund as of the commencement of the Offer, or (vii) other event or condition that would have a material adverse effect on the Fund or its Stockholders if Shares tendered pursuant to the Offer were purchased; or (c) the Independent Directors of the Fund determine that it is not in the best interest of the Fund to purchase Shares pursuant to the Offer. However, there can be no assurance that the Fund will exercise its right to extend, amend or cancel the Offer or to postpone acceptance of tenders pursuant to the Offer.

&nbsp;&nbsp;&nbsp;&nbsp;8. Certain Information About the Fund

The Fund is a non-diversified, closed-end management investment company registered under the 1940 Act and is organized as a Maryland corporation. The principal executive office of the Fund is located at 30 Hudson Yards, New York, New York 10001 and the telephone number is (212) 750-8300. Shares are not traded on any established trading market.

The Fund does not have any plans or proposals that relate to or would result in: (a) the acquisition by any person of additional Shares (other than the Fund's intention to accept purchases for Shares from time to time, the DRIP or otherwise in the discretion of the Fund) or the disposition of Shares (except for periodic discretionary solicitations of tender offers); (b) an extraordinary transaction, such as a merger, reorganization or liquidation, involving the Fund (c) any material change in the present distribution policy or indebtedness or capitalization of the Fund; (d) any change in the identity of the investment adviser or Directors of the Fund, or in the management of the Fund including, but not limited to, any plans or proposals to change the number or the term of the Directors, to change any material term of the investment advisory arrangements with the Adviser; (e) a sale or transfer of a material amount of assets of the Fund (other than as the Directors determine may be necessary or appropriate to fund any portion of the purchase price for Shares acquired pursuant to this Offer to Purchase or in connection with the ordinary portfolio transactions of the Fund); (f) any other material change in the Fund's structure or business, including any plans or proposals to make any changes in its fundamental investment policy for which a vote would be required by Section 13 of the 1940 Act; or (g) any changes in the Articles of Incorporation, as amended, Bylaws, or Prospectus or other actions that may impede the acquisition of control of the Fund by any person.

8 of 13

------

![LOGO](g949685g11g11.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;8. Certain Information About the Fund *(continued)*

Based on the number of Shares outstanding as of November 26, 2025**,** the following persons (the named individuals being the Directors and officers) own the number of Shares indicated in the below table:

---

| | | |
|:---|:---|:---|
| **Person** | **Shares** | **Percentage of the Fund's**<br> **Outstanding Shares** |
|  Adviser | 10954992.20 | 18.64% |
|  Ralph Rosenberg | 47439.66 | \* |
|  Fran Bermanzohn | 12723.91 | \* |
|  Joan Binstock | 15579.69 | \* |
|  James Kropp | 21907.73 | \* |
|  Susan Meaney | 11264.24 | \* |
|  Nicholas O'Neill |  | \* |
|  Megan Gaul |  | \* |
|  Julia Butler | 3935.50 | \* |
|  James Amler |  | \* |
|  Lori Hoffman |  | \* |
|  Doug Krupa |  | \* |
|  Matt Salem |  | \* |
|  \* Less than 1%. |  |  |

---

Based on information available to the Fund, none of the persons listed above intends to tender any of his or her Shares in the Offer.

Reference is made to Section 8 "Certain Information About the Fund" of the Offer to Repurchase, which is incorporated herein by reference. Other than the issuance of Shares by the Fund in the ordinary course of business, there have been no transactions in Shares effected during the past sixty (60) days by the Fund, the Adviser, or any Director or officer of the Fund, or any person controlling the Fund or the Adviser.

&nbsp;&nbsp;&nbsp;&nbsp;9. Shareholder Priority Plan and NAV Support Agreement

On June 4, 2024, KAA, an affiliate of the Adviser, contractually committed to the Fund to continue to hold approximately 7,732,436 of Support Shares, through June 1, 2027 and, to the extent necessary, contribute such shares to the Fund to support a NAV per share of $27.00 on June 1, 2027. If on June 1, 2027 the Fund's NAV per share is less than $27.00 per share for any share class, KAA will contribute to the Fund as many of the Support Shares as are required, up to the maximum number of Support Shares, to reduce the number of outstanding shares and increase the NAV per share for each class of the Fund's shares up to $27.00 per share. If the Fund's NAV per share for any class on June 1, 2027 is less than $27.00 per share and the contribution of all of the Support Shares is not sufficient to cause the NAV per share for each class to equal $27.00 per share, KAA will contribute all such Support Shares to support the Fund's NAV per share on such date. While the Shareholder Priority Plan is a contractual obligation to support the Fund's NAV per share, there is no guarantee that the contribution of the Support Shares will be sufficient to achieve a $27.00 per share NAV on June 1, 2027. For the avoidance of doubt, KAA is not obligated to contribute any of the Support Shares prior to June 1, 2027, and KAA is not obligated to contribute any of the Support Shares if the NAV per share for each class equals or exceeds $27.00 per share on June 1, 2027. All Fund shareholders on June 1, 2027 will benefit from this agreement. Existing shareholders do not need to take any action to take advantage of this opportunity.

9 of 13

------

![LOGO](g949685g11g11.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;10. Full Tender by DRIP Participants

If you are a participant in the DRIP, in the event you elect to tender your Shares in full, your participation in the DRIP will be automatically terminated as of the applicable Expiration Date and any distributions due but not yet paid as of such date will be paid in cash on the scheduled distribution payment date.

&nbsp;&nbsp;&nbsp;&nbsp;11. Certain Federal Income Tax Consequences

The following summary describes certain of the material U.S. federal income tax consequences relating to the purchase of Shares by the Fund from Stockholders pursuant to the Offer. Except where noted, this summary deals only with Shares held as a capital asset and does not deal with special situations, such as those of dealers in securities or currencies, financial institutions, regulated investment companies, tax-exempt entities, insurance companies, persons holding Shares as a part of a hedging, integrated, conversion or constructive sale transaction or a straddle, traders in securities that elect to use a mark-to-market method of accounting for their securities holdings, persons liable for alternative minimum tax, persons who are "foreign governments" within the meaning of Section 892 of the Internal Revenue Code of 1986, as amended (the "Code"), investors in pass-through entities or U.S. holders of Shares whose "functional currency" is not the U.S. dollar. Furthermore, the discussion below is based upon the provisions of the Code and regulations, rulings and judicial decisions thereunder as of the date hereof, and such authorities may be repealed, revoked or modified, possibly with retroactive effect, so as to result in U.S. federal income tax consequences different from those discussed below. No ruling on the U.S. federal, state, or local tax considerations relevant to the purchase of Shares by the Fund has been requested from the IRS or other tax authority. No assurance can be given that the IRS would not assert, or that a court would not sustain, a position contrary to any of the tax consequences described below. The summary is also based upon the assumption that we and our subsidiaries and affiliated entities will operate in accordance with our and their applicable organizational documents.

The U.S. federal income tax treatment of holders of our Shares depends in some instances on determinations of fact and interpretations of complex provisions of U.S. federal income tax law for which no clear precedent or authority may be available. In addition, the tax consequences to any particular Stockholder of holding Shares will depend on the Stockholder's particular tax circumstances. You are urged to consult your own tax advisors concerning the U.S. federal income tax consequences in light of your particular situation as well as consequences arising under the laws of any other taxing jurisdiction.

As used in the remainder of this discussion, the term "U.S. Stockholder" refers to a Stockholder that is for U.S. federal income tax purposes (i) a citizen or resident of the United States, (ii) a corporation (or an entity treated as a corporation for U.S. federal income tax purposes) created or organized in or under the laws of the United States, any State thereof or the District of Columbia, (iii) an estate the income of which is subject to U.S. federal income taxation regardless of its source; or (iv) a trust if it (x) is subject to the primary supervision of a court within the United States and one or more U.S. persons have the authority to control all substantial decisions of the trust or (y) has a valid election in effect under applicable Treasury regulations to be treated as a U.S. person.

If a partnership (or an entity treated as a partnership for U.S. federal income tax purposes) holds Shares, the tax treatment of a partner will generally depend upon the status of the partner and the activities of the partnership. If you are a partner of a partnership holding Shares, you should consult your advisors.

A "Non-U.S. Stockholder" is a beneficial owner of Shares that is neither a U.S. holder nor a partnership (or an entity treated as a partnership for U.S. federal income tax purposes). Except for the discussion under "Non-U.S. Stockholders," the following discussion is limited to U.S. Stockholders.

For more detailed information regarding tax considerations applicable to a purchase of Shares by the Fund pursuant to the Offer, and ownership of Shares of the Fund in general, see the Fund's Prospectus.

10 of 13

------

![LOGO](g949685g11g11.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;11. Certain Federal Income Tax Consequences *(continued)*

**U.S. Stockholders.** An exchange of Shares for cash in the Offer will be a taxable transaction for U.S. federal income tax purposes. As a consequence of the exchange, a tendering U.S. Stockholder will, depending on such Stockholder's particular circumstances, be treated either as recognizing gain or loss from the disposition of the Shares or as receiving a dividend distribution from the Fund. Under Section 302(b) of the Code, a sale of Shares pursuant to the Offer generally will be treated as a sale or exchange if the receipt of cash by the Stockholder: (a) results in a complete termination of the Stockholder's interest in the Fund, (b) results in a substantially disproportionate redemption with respect to the Stockholder, or (c) is not essentially equivalent to a dividend with respect to the Stockholder. In determining whether any of these tests have been met, Shares actually owned, as well as Shares considered to be owned by the Stockholder by reason of certain constructive ownership rules set forth in Section 318 of the Code, generally must be taken into account. The sale of Shares pursuant to the Offer generally will result in a "substantially disproportionate" redemption with respect to a Stockholder if the percentage of the Fund's then outstanding voting stock owned by the Stockholder immediately after the sale is less than 80% of the percentage of the Fund's voting stock owned by the Stockholder determined immediately before the sale. The sale of Shares pursuant to the Offer generally will be treated as "not essentially equivalent to a dividend" with respect to a Stockholder if the reduction in the Stockholder's proportionate interest in the Fund's stock as a result of the Fund's purchase of Shares constitutes a "meaningful reduction" of the Stockholder's interest. If any of the above three tests for sale or exchange treatment is met, a U.S. Stockholder will recognize gain or loss equal to the difference between the price paid by the Fund for the Shares purchased in the Offer and the Stockholder's adjusted basis in such Shares. If such Shares are held as a capital asset, the gain or loss will be capital gain or loss. Gain or loss will be determined separately for blocks of Shares acquired at different times or at different prices. The maximum tax rate applicable to capital gains recognized by individuals and other non-corporate taxpayers is (i) the same as the applicable ordinary income rate for capital assets held for one year or less or (ii) 20% for capital assets held for more than one year. The deductibility of capital losses is subject to limitations.

If the requirements of Section 302(b) of the Code are not met, amounts received by a Stockholder who sells Shares pursuant to the Offer will be taxable to the Stockholder as a dividend to the extent of such Stockholder's allocable share of the Fund's current or accumulated earnings and profits. To the extent that amounts received exceed such Stockholder's allocable share of the Fund's current and accumulated earnings and profits for a taxable year, the distribution will first be treated as a non-taxable return of capital, causing a reduction in the adjusted basis of such Stockholder's Shares, and any amounts in excess of the Stockholder's adjusted basis will constitute taxable gain. Any remaining adjusted basis in the Shares tendered to the Fund will be transferred to any remaining Shares held by such Stockholder.

If the payment for any purchase of Shares pursuant to the Offer is treated as a taxable dividend to the selling Stockholder rather than as an exchange, the other Stockholders, including the non-tendering U.S. Stockholders, could be deemed to have received taxable stock distributions under certain circumstances. Stockholders are urged to consult their own tax advisors regarding the possibility of deemed distributions resulting from the purchase of Shares pursuant to the Offer.

**Non-U.S. Stockholders.** The Transfer Agent or applicable withholding agent may withhold U.S. federal income taxes equal to 30% of the gross payments payable to a Non-U.S. Stockholder or his or her agent unless the Transfer Agent or applicable withholding agent determines that a reduced rate of withholding is available pursuant to a tax treaty or that an exemption from withholding is applicable because such gross proceeds are effectively connected with the conduct of a trade or business within the U.S. In order to obtain a reduced rate of withholding pursuant to a tax treaty, a Non-U.S. Stockholder must deliver to the Transfer Agent or applicable withholding agent before the payment a properly completed and executed IRS Form W-8BEN (for individuals) or Form W-8BEN-E (for entities). In order to obtain an exemption from withholding on the grounds that the gross proceeds paid pursuant to the Offer are effectively connected with the conduct of a trade or business within the U.S., a Non-U.S. Stockholder must deliver to the Transfer Agent or applicable withholding agent a properly completed and executed IRS Form W-8ECI. The Transfer Agent or applicable withholding agent will determine a Stockholder's status as a Non-U.S. Stockholder and eligibility for a reduced rate of, or exemption from, withholding by reference to any outstanding certificates or statements concerning eligibility for a reduced rate of, or exemption from, withholding (e.g., IRS Forms W-8BEN, W-8BEN-E or W-8ECI) unless facts and circumstances indicate that such reliance is not warranted. A Non-U.S. Stockholder may be eligible to obtain a refund of all or a portion of any tax

11 of 13

------

![LOGO](g949685g11g11.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;11. Certain Federal Income Tax Consequences *(continued)*

withheld if such Non-U.S. Stockholder meets one of the "complete termination," "substantially disproportionate" or "not essentially equivalent to a dividend" tests described above or is otherwise able to establish that no tax or a reduced amount of tax is due. Backup withholding (discussed below) generally will not apply to amounts subject to the 30% or a treaty-reduced rate of withholding. Non-U.S. Stockholders are urged to consult their own tax advisors regarding the application of U.S. federal income tax withholding, including eligibility for a withholding tax reduction or exemption, and the refund procedure.

If the payment for any purchase of Shares pursuant to the Offer is treated as a taxable dividend to the selling Stockholder rather than as an exchange, the other Stockholders, including the non-tendering Non-U.S. Stockholders, could be deemed to have received taxable stock distributions under certain circumstances. Stockholders are urged to consult their own tax advisors regarding the possibility of deemed distributions resulting from the purchase of Shares pursuant to the Offer.

In addition, a Non-U.S. Stockholder (other than an individual) may be subject to a 30% withholding tax under FATCA unless such Non-U.S. Stockholder establishes an exemption from such withholding tax under FATCA, typically on IRS Form W-8BEN-E. If the Transfer Agent or applicable withholding agent withholds any amounts under FATCA, such amounts will be credited against any withholding due for U.S. federal income tax.

For more detailed information regarding tax considerations applicable to a purchase of Shares by the Fund from a Non-U.S. Stockholder pursuant to the Offer, including considerations relating to the Foreign Investment in Real Property Tax Act of 1980, as amended, see the Fund's Prospectus.

**Backup Federal Income Tax Withholding.** Backup withholding tax will be imposed on the gross proceeds paid to a tendering U.S. Stockholder unless the U.S. Stockholder provides to the Transfer Agent or applicable withholding agent a correct U.S. taxpayer identification number, certifies that such U.S. Stockholder is exempt from backup withholding and otherwise complies with applicable requirements of the backup withholding rules. Therefore, each tendering U.S. Stockholder must complete and sign an Internal Revenue Service ("IRS") Form W-9 prior to the payment so as to provide the information and certification necessary to avoid backup withholding, unless such U.S. Stockholder otherwise establishes to the satisfaction of the Transfer Agent or applicable withholding agent that such U.S. Stockholder is not subject to backup withholding. Certain U.S. Stockholders (including, among others, most corporations) are not subject to these backup withholding requirements. In addition, Non-U.S. Stockholders are not subject to these withholding requirements. In order for a Non-U.S. Stockholder to qualify as an exempt recipient, that Non-U.S. Stockholder generally must submit an applicable IRS Form W-8 (generally, an IRS Form W-8BEN, W-8BEN-E or W-8ECI).

**The tax discussion set forth above is included for general information only. Each Stockholder is urged to consult his or her own tax advisor to determine the particular tax consequences to him or her of the Offer, including the applicability and effect of state, local and foreign tax laws.**

&nbsp;&nbsp;&nbsp;&nbsp;12. Miscellaneous

The Offer is not being made to, nor will tenders be accepted from, Stockholders in any jurisdiction in which the Offer or its acceptance would not comply with the securities or Blue Sky laws of such jurisdiction. The Fund is not aware of any jurisdiction in which the Offer or tenders pursuant thereto would not be in compliance with the laws of such jurisdiction. However, the Fund reserves the right to exclude Stockholders from the Offer in any jurisdiction in which it is asserted that the Offer cannot lawfully be made. The Fund believes such exclusion is permissible under applicable laws and regulations, provided the Fund makes a good faith effort to comply with any state law deemed applicable to the Offer.

The Fund has filed an Issuer Tender Offer Statement on Schedule TO with the Securities and Exchange Commission (the "SEC"), which includes certain information relating to the Offer summarized herein. A free copy of such statement may be obtained from the Fund at <u>www.krest.reit</u>, by contacting the Transfer Agent at (855) 844-8655, or from the SEC's internet web site, <u>http://www.sec.gov</u>.

12 of 13

------

![LOGO](g949685g11g11.jpg)

&nbsp;&nbsp;&nbsp;&nbsp;13. Financial Statements

Financial statements have not been included herein because the consideration offered to shareholders consists solely of cash; the Offer is not subject to any financing condition; and the Company is a public reporting company under Section 13(a) of the Exchange Act, and files its reports electronically on the EDGAR system.

Reports and other information about the Company are available on the EDGAR Database on the SEC's Internet site (<u>http://www.sec.gov.</u>) and copies of this information may be obtained, after paying a duplicating fee, by electronic request at the following E-mail address: <u>publicinfo@sec.gov.</u>

13 of 13

## Ex-99.(A)(1)(Iii)

**Exhibit (a)(1)(iii)** 

---

| | |
|:---|:---|
| ![LOGO](g949685g11g11.jpg) <br>| ![LOGO](g949685g08g08.jpg) |

---

## Letter of Transmittal
Regarding Shares in KKR Real Estate Select Trust Inc.

Tendered Pursuant to the Offer to Purchase

Dated December 10, 2025

*The Offer and withdrawal rights will expire on January 9, 2026 and this Letter of Transmittal must be received by the Fund's Transfer Agent, either by mail, or by fax, or by email, by 4:00 p.m., Eastern Time, on January 9, 2026, unless the Offer is extended* 

*Complete this Letter of Transmittal and follow the Transmittal Instructions included herein* 

Ladies and Gentlemen:

The undersigned hereby tenders to KKR Real Estate Select Trust Inc., a non-diversified, closed-end management investment company registered under the Investment Company Act of 1940, as amended (the "1940 Act"), and organized as a Maryland corporation (the "Fund"), the shares of common stock in the Fund or portion thereof held by the undersigned, described and specified below, on the terms and conditions set forth in the Offer to Purchase dated December 10, 2025 (the "Offer to Purchase"), receipt of which is hereby acknowledged, and in this Letter of Transmittal (which together with the Offer to Purchase constitute the "Offer"). *The tender and this Letter of Transmittal are subject to all the terms and conditions set forth in the Offer to Purchase, including, but not limited to, the absolute right of the Fund to reject any and all tenders determined by it, in its sole discretion, not to be in the appropriate form.*

The undersigned hereby sells to the Fund the shares of common stock in the Fund or portion thereof tendered hereby pursuant to the Offer.

The undersigned hereby warrants that the undersigned has full authority to sell the shares of common stock in the Fund or portions thereof tendered hereby and that the Fund will acquire good title thereto, free and clear of all liens, charges, encumbrances, conditional sales agreements or other obligations relating to the sale thereof, and not subject to any adverse claim, when and to the extent the same are purchased by it. Upon request, the undersigned will execute and deliver any additional documents necessary to complete the sale in accordance with the terms of the Offer. The undersigned recognizes that under certain circumstances set forth in the Offer, the Fund may not be required to purchase any of the shares of common stock in the Fund or portions thereof tendered hereby.

If the undersigned is a participant in the Fund's distribution reinvestment plan ("DRIP"), in the event that the undersigned tenders all of their shares in the Offer (whether or not the Fund accepts all such shares for payment pursuant to the Offer), the undersigned hereby elects to withdraw from participation in the DRIP effective as of the applicable Expiration Date, and the undersigned hereby acknowledges that any distributions due but not yet paid as of such date will be paid in cash on the scheduled distribution date.

A non-transferable, non-interest bearing promissory note for the purchase price will be issued to the undersigned if the Fund accepts for purchase the shares tendered hereby. The undersigned acknowledges that SS&C Global Investor & Distribution Solutions, Inc., the Fund's transfer agent, will hold the promissory note on behalf of the undersigned. The cash payment(s) of the purchase price for the shares of common stock in the Fund or portion thereof of the undersigned, as described in Section 6 "Purchases and Payment" of the Offer to Purchase, shall be wired to the account at your financial intermediary from which your subscription funds were debited.

1 of 4

------

![LOGO](g949685g11g11.jpg)

All authority herein conferred or agreed to be conferred shall survive the death or incapacity of the undersigned and the obligation of the undersigned hereunder shall be binding on the heirs, personal representatives, successors and assigns of the undersigned. Except as stated in Section 5 "Withdrawal Rights" of the Offer to Purchase, this tender is irrevocable.

**<u>VALUATION DATE</u>: January 9, 2026** 

**<u>TENDER OFFER EXPIRATION DATE</u>: 4:00 p.m. (Eastern Time), January 9, 2026** 

**PARTS 1, 2, 3, AND 4 MUST BE COMPLETED AND IN GOOD ORDER IN ORDER TO PROCESS YOUR REQUEST** 

**If You Invest In The Fund Through A Financial Intermediary Through Whom You Expect To Have Your Tender Offer Request Submitted, Please Allow For Additional Processing Time As The <u>Letter of Transmittal Must Ultimately Be Received By The Fund's Transfer Agent No Later Than 4:00 p.m. (Eastern Time) On The Expiration Date</u>.** 

**PLEASE FAX OR MAIL TO THE FUND'S TRANSFER AGENT AT:** 

---

| | |
|:---|:---|
| *Regular Mail* | *Fax: (833) 674-0748* |
| SS&C Global Investor & Distribution Solutions, Inc.<br> Attn: KKR Democratized Access Vehicles<br> c/o: SS&C GIDS, Inc.<br> P.O. Box 219302<br> Kansas City, MO 64121-9302 | FOR ADDITIONAL INFORMATION CALL:<br> (855) 844-8655 |

---

*Overnight or Express Mail* 

SS&C Global Investor & Distribution Solutions, Inc.

Attn: KKR Democratized Access Vehicles

c/o: SS&C GIDS, Inc.

801 Pennsylvania Ave, Suite 219302

Kansas City, MO 64105-1307

Email:

<u>KKRREDEEM.ai@sscinc.com</u>

**Note:** This is a submission box only, no response will be provided to any general or follow up inquiries.

2 of 4

------

![LOGO](g949685g11g11.jpg)

---

| | |
|:---|:---|
| **PART 1 –** | **NAME (AS IT APPEARS ON YOUR KKR REAL ESTATE SELECT TRUST INC. STATEMENT) AND CONTACT INFORMATION** |

---

---

| |
|:---|
|  Fund Name:<br>|
|  Fund Account #:<br>|
|  Account Name/Registration:<br>|
|  Address:<br>|
|  City, State, Zip<br>|
|  Telephone Number:<br>|
|  Email Address:<br>|
|  Financial Intermediary Firm Name:<br>|
|  Financial Intermediary Account #:<br>|
|  Financial Advisor Name:<br>|
|  Financial Advisor Telephone #:<br>|

---

**PART 2 – REQUESTED TENDER AMOUNT** 

**Please select repurchase type by checking one of the boxes below. If you are requesting a partial repurchase, please provide a number of Shares.** 

---

| |
|:---|
| Full Repurchase |
| Partial Repurchase\* of<u> </u> Class I Shares (please only provide a number of Shares, **<u>not</u>** a dollar amount) |
| Partial Repurchase\* of<u> </u> Class D Shares (please only provide a number of Shares, **<u>not</u>** a dollar amount) |
| Partial Repurchase\* of<u> </u> Class S Shares (please only provide a number of Shares, **<u>not</u>** a dollar amount) |
| Partial Repurchase\* of<u> </u> Class U Shares (please only provide a number of Shares, **<u>not</u>** a dollar amount) |
| If the requested partial repurchase would put the account balance below the required minimum balance, the Fund may reduce the amount to be repurchased such that the required minimum balance is maintained, unless you indicate otherwise by checking the following box: |
| Change request to Full Repurchase if amount requested to be repurchased would need to be reduced to maintain minimum account balance. |

---

**KKR REAL ESTATE SELECT TRUST INC. ACCOUNT #: (Should be the same as on page 2)** 

**PART 3 – PAYMENT** 

Payments will be made to the shareholder's account in accordance with the standard procedures of such shareholder's intermediary, when applicable, or to the shareholder's existing payment instruction on file. Contact your financial intermediary or account manager if you have any questions.

3 of 4

------

![LOGO](g949685g11g11.jpg)

**PART 4 – SIGNATURE(S)** 

The undersigned subscriber acknowledges that this request is subject to all the terms and conditions set forth in the Fund's Prospectus and the Offer to Purchase and all capitalized terms used herein have the meaning as defined in the Fund's Prospectus. This request is irrevocable except as described in the Offer to Purchase. The undersigned represents that the undersigned is the beneficial owner of the shares in the Fund to which this repurchase request relates, or that the person signing this request is an authorized representative of the tendering stockholder.

In the case of joint accounts, each joint holder must sign this repurchase request. Requests on behalf of a foundation, partnership or any other entity should be accompanied by evidence of the authority of the person(s) signing.

**If Shares are registered in the name of a custodian, the custodian of the Shares must execute this Repurchase Request Form, and the beneficial owner of the Shares hereby authorizes and directs the custodian of the Shares to execute this Repurchase Request Form.** 

**Beneficial Owner Signature:** 

---

| | |
|:---|:---|
| Print Name of Beneficial Owner<br>| Print Name of Co-Beneficial Owner<br>|
| Title of Signatory if Acting in a Representative Capacity<br>| Title of Signatory if Acting in a Representative Capacity<br>|
| **Signature – Beneficial Owner**<br>| **Signature – Co-Beneficial Owner**<br>|
| **Date** | **Date** |

---

**Registered Holder Signature (if different than above; print name exactly as it appears on the subscription agreement or as indicated on the stock ledger maintained by the Fund's transfer agent):** 

---

| |
|:---|
| Signature – Registered Holder |
| Print Name of Registered Holder |
| Title of Signatory |
| Date |

---

4 of 4

## Ex-99.(A)(1)(Iv)

**Exhibit (a)(1)(iv)** 

---

| | |
|:---|:---|
| ![LOGO](g949685g11g11.jpg) <br>| ![LOGO](g949685g08g08.jpg) |

---

## Notice of Withdrawal of Tender
Regarding Shares in KKR Real Estate Select Trust Inc.

Tendered Pursuant to the Offer to Purchase

Dated December 10, 2025

*The Offer and withdrawal rights will expire on January 9, 2026 and this Notice of Withdrawal must be received by the Fund's Transfer Agent, either by mail, or by fax, or by email, by 4:00 p.m., Eastern Time, on January 9, 2026, unless the Offer is extended* 

*Complete this Notice of Withdrawal and follow the transmittal instructions included herein* 

**PLEASE SEND COMPLETED FORMS TO YOUR FINANCIAL ADVISOR / PORTFOLIO MANAGER** 

You are responsible for confirming that this Notice is received timely by your Financial Advisor or Portfolio Manager. If you fail to confirm receipt of this Notice, there can be no assurance that your withdrawal will be honored by the Fund.

Ladies and Gentlemen:

Please withdraw the tender previously submitted by the undersigned in a Letter of Transmittal.

---

| |
|:---|
|  Fund Name:<br>|
|  Fund Account #:<br>|
|  Account Name/Registration:<br>|
|  Address:<br>|
|  City, State, Zip<br>|
|  Telephone Number:<br>|
|  Email Address:<br>|
|  Financial Intermediary Firm Name:<br>|
|  Financial Intermediary Account #:<br>|
|  Financial Advisor Name:<br>|
|  Financial Advisor Telephone #:<br>|

---

The undersigned represents that the undersigned is the owner of the common stock in the Fund to which this withdrawal request relates, or that the person signing this request is an authorized representative of the withdrawing shareholder.

1 of 2

------

![LOGO](g949685g11g11.jpg)

In the case of joint accounts, each joint holder must sign this withdrawal request. Requests on behalf of a foundation, partnership or any other entity should be accompanied by evidence of the authority of the person(s) signing.

  <u> Signature</u> Print Name of Authorized Signatory (and Title if applicable)   <u>Date</u> <br> Signature Print Name of Authorized Signatory (and Title if applicable) Date

---

| | |
|:---|:---|
| *Regular Mail* | *Fax:* (833) 674-0748 |
| SS&C Global Investor & Distribution Solutions, Inc.<br> Attn: KKR Democratized Access Vehicles<br> c/o: SS&C GIDS, Inc.<br> P.O. Box 219302<br> Kansas City, MO 64121-9302 | FOR ADDITIONAL INFORMATION CALL:<br> (855) 844-8655 |

---

*Overnight Mail*

SS&C Global Investor & Distribution Solutions, Inc.

Attn: KKR Democratized Access Vehicles

c/o: SS&C GIDS, Inc.

801 Pennsylvania Ave

Suite 219302

Kansas City, MO 64105-1307

*Email:*

<u>KKRREDEEM.ai@sscinc.com</u>

**Note:** This is a submission box only, no response will be provided to any general or follow up inquiries.

You have the right to withdraw your tendered Shares at any time until 4:00 p.m., Eastern Time, on January 9, 2026 or, if such tendered Shares have not been accepted by the Fund, at any time after February 9, 2026.

You are responsible for confirming that this Notice is received timely by SS&C Global Investor & Distribution Solutions, Inc., the Fund's transfer agent. To assure good delivery, please send this page to SS&C Global Investor & Distribution Solutions, Inc. and not to your financial advisor. If you fail to confirm receipt of this Notice, there can be no assurance that your withdrawal will be honored by the Fund.

2 of 2

## Ex-Filing

?xml version='1.0' encoding='ASCII'? EX-FILING FEES

 **Calculation of Filing Fee Tables** <br>

---

| | | | | |
|:---|:---|:---|:---|:---|
| | | **Transaction Valuation**  | **Fee Rate**  | **Amount of Filing Fee**  |
| Fees to be Paid | 1 | $69128282.67 | 0.0001381 | $9546.62 |
| Fees Previously Paid |  |  |  |  |
|  | Total Transaction Valuation: | $69128282.67  |  |  |
|  | Total Fees Due for Filing: |  |  | $9546.62  |
|  | Total Fees Previously Paid:  |  |  | $0.00  |
|  | Total Fee Offsets:  |  |  | $0.00  |
|  | Net Fee Due:  |  |  | $9546.62  |

---

 **Offering Note** <br>

<sup>1</sup> (a) Calculated as the aggregate maximum purchase price for shares of common stock, based upon the net asset value per share as of November 26, 2025, of $23.53. This amount is based upon the offer to purchase up to 2,937,879 shares of common stock, par value $0.01 per share, of KKR Real Estate Select Trust Inc. (b) Calculated at $138.10 per $1,000,000.00 of the Transaction Valuation in accordance with Rule 0-11 under the Securities Exchange Act of 1934, as amended, as modified by the Filing Fee Rate Advisory for fiscal year 2026.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | | Registrant or Filer Name | Form or Filing Type | File Number | Initial Filing Date | Filing Date | Fee Offset Claimed | Fee Paid with Fee Offset Source |
| Fee Offset Claims | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Fee Offset Sources | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |

---